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ABSTRACT
Human yD crystallin (HyD-Crys) and human yS crystallin (HyS-Crys), are major
proteins of the human eye lens and are components of cataracts. HyD-Crys is expressed
early in life in the lens cortex while HyS-Crys is expressed throughout life in the lens
epithelial cells. Both are primarily n-sheet proteins made up of four Greek keys
separated into two domains and display 69% sequence similarity.
The unfolding and refolding of HyD-Crys and HyS-Crys have been characterized
as a function of guanidinium hydrochloride (GdnHCl) concentration at neutral pH and
37°C, using intrinsic tryptophan fluorescence to monitor in vitro folding. Equilibrium
unfolding and refolding experiments with GdnHCl showed unfolded protein is more
fluorescent than its native counter-part despite the absence of metal or ion-tryptophan
interactions in both of these proteins. This fluorescence quenching may influence the
lens response to ultraviolet light radiation or the protection of the retina from ambient
ultraviolet damage.
Wild-type HyD-Crys exhibited reversible refolding above 1.0 M GdnHCl.
Aggregation of refolding intermediates of HyD-Crys was observed in both equilibrium
and kinetic refolding processes. The aggregation pathway competed with productive
refolding at denaturant concentrations below 1.0 M GdnHCl, beyond the major
conformational transition region. HyS-Crys, however, exhibited a two-state reversible
unfolding and refolding with no evidence of aggregation. Atomic force microscopy of
HyD-Crys samples under aggregating conditions revealed ordered fiber structures that
could recruit HyS-Crys to the aggregate.
To provide fluorescence reporters for each quadrant of HyD-Crys, triple mutants
each containing three tryptophan to phenylalanine substitutions and one native tryptophan
have been constructed and expressed. Trp68-only and Trp 156-only retained the
quenching pattern of wild-type HyD-Crys.
During equilibrium refolding/unfolding, the tryptophan fluorescence signals indicated
that domain I (W42-only and W68-only) unfolded at lower concentrations of GdnHCl
than domain II (W130-only and W156-only). Kinetic analysis of both the unfolding and
refolding of the triple mutant tryptophan proteins identified an intermediate along the
HyD-Crys folding pathway with domain I unfolded and domain II
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intact. This species is a candidate for the partially folded intermediate in the in vitro
aggregation pathway of HyD-Crys.
An N143D deamination post-translational modification has recently been
identified in HyS-Crys that is present in high concentrations in insoluble protein removed
from cataractous lenses. The presence of the N143D mutation did not significantly affect
the equilibrium or kinetic properties of HyS-Crys indicating that this mutation is unlikely
to be involved in protein destabilization during cataract formation in vivo.
The method in which HyD-Crys aggregates on its own and engages neighboring
molecules in the polymerization process in vitro may provide insight into the process of
cataractogenesis in vivo.
Thesis Supervisor: Dr. Jonathan King, Professor of Biology
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CHAPTER I: INTRODUCTION
A. THE PROTEIN FOLDING PROBLEM
The biomedical research community has been inundated with new technologies
and discoveries that seem to be multiplying at an exponential rate. Things that seemed
completely unattainable just five or ten years ago have now been transformed into routine
procedures that are taught to introductory biology majors and sold as ready-made kits
from mass manufacturing companies. For example, RNA interference loops and micro-
array gene chips are customizable at a touch of a button, and a few minutes at a computer
keyboard will align a newly discovered gene with hundred of possible functional cousins.
Perhaps the most striking advance in the scientific world has been in DNA
manipulation and sequencing. DNA sequencing has become so accessible at large
throughput facilities that the average incoming biochemistry student has never even seen
the massive glass plates that were used historically for these experiments, never mind
actually run a sequencing gel. The biomedical community has successfully sequenced
entire genomes including many animal model organisms such as C. elegans, S.
Cerevisiae, and the mouse. The majority of the human genome was successfully
completed in 2001 by two competing groups (Lander et al. 2001 and Venter et al. 2001).
We now possess every chromosomal coding sequence in the human cell. In essence, that
means we know the sequence of every RNA and, perhaps most shockingly, a possible
sequence for every protein that sustains human life! Unfortunately, unlike the
sequencing of the human genome, there is no shot-gun method of folding a protein when
faced with simply its amino acid sequence.
Protein sequence dictates structure and polypeptide structure controls protein
function. We now have half of the code needed to break the mystery of how proteins
fold. We have the sequence, we need to be able to understand and predict the formation
of structure from this information. As early as 1960, Christian Anfinsen set out upon this
lofty goal and subsequently won the Nobel Prize for his insights into protein folding as a
sequence guided process. Numerous scientists have spent their entire careers trying to
unravel the "second-half' of the genetic code. We are flying at light speed in other
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scientific arenas, but in the world of protein folding, we are moving relatively at a snail's
pace. How does a linear sequence of amino acids actually control and maintain a
complex three-dimensional protein fold? Moreover, how does this complex fold become
altered and manipulated in protein deposition disorders?
i. The models of protein folding: framework versus hydrophobic collapse
There are two conceptual models most frequently used to describe the events that
occur in protein folding. In the frame-work model, isolated pieces of secondary structure
form independently in regions of the polypeptide chain upon folding (Ptitsyn 1998,
Goldberg 1969, Wetlaufer 1973, Jaenicke 1999). These isolated a-helices, P-sheets, and
loops then come together forming the native tertiary contacts. Alternatively, in the
hydrophobic collapse model, upon folding, the polypeptide chain undergoes a rapid
compaction in which the hydrophobic residues come together and form a rigid core (Dill
and Chan 1997, Onuchic et al. 1997, Eaton et al. 1997). The hydrophobic core provides a
stabilized center around which the native secondary structure forms.
Some combination of both of these mechanisms is probably applicable for most
proteins containing a-helices and 3-sheets. One reasonable approach to tackling the
grand problem of protein folding is to understand the kinetic and thermodynamic
properties of each class of secondary structure separately.
ii. Folding of a-helical proteins
Some headway has been made in understanding the propensity of an amino acid
sequence to adopt an a-helical conformation (Mufioz and Serrano 1995). There are 3.6
residues per turn in an a-helix, and this means that within an isolated helix, one amino
acid will interact only with other amino acids within a four residue linear distance of
itself. In cases in which short-range interactions of i to i+4 between residues are
dominant, estimations of secondary structure may be determined from knowledge of
linear sequence interactions. These local interactions allow a rapid backbone hydrogen-
17
bonding network to be established for -helices that results in complete folding within
the millisecond time scale (Capaldi and Radford 1998).
For sequences of amino acids within a polypeptide chain in which local
interactions dominate, we can generally assess the ability and likelihood that the
sequence in question will form an a-helix based on the type of amino acids involved and
the "capping" residues at the end of the sequence. Specifically, our ability to predict
coiled-coil domains or the collagen triple helix fold is making progress (Hu et al. 1990,
Brodsky and Ramshaw 1997).
In the cases of coiled-coils or four helix bundles, interactions between helices are
reasonably well understood as well. The heptad repeat is a predictable motif observed in
these types of interacting helices controlling individual helix stability and interaction
energies (Cohen and Parry 1990, O'Shea et al. 1991). The stabilities and conformations
of four-helix bundles are controlled by local and capping interactions as described above,
together with the "knobs into holes" packing between helices (Dunker and Jones 1978).
Successful de novo design of four-helix bundles has been achieved based on knowledge
of hydrophobic packing, conformational entropy, interhelical turn residues, and helix-
dipole interactions (Kamtekar and Hecht 1995). Specifically, the structure and stability
of hydrophobic point mutants for homodimeric and heterodimeric coiled-coils may be
calculated accurately based on side-chain packing interactions (Keating et al. 2001).
ii. Folding of f-sheet proteins
With the progress in understanding -helical conformations, many laboratories
have now turned their attention away to a more elusive problem; [-sheet folding. To
understand -sheet protein folding, we cannot simply look at the primary sequence of
amino acids in a protein and predict what interaction will be present in the final P-fold.
The global sequence control of residues involved in n-sheets could perhaps extend from
residue i to residue i+4 or from residue i to residue i+204. In other words, one amino
acid may be conformationally stabilized into a -sheet structure by interaction with others
residues throughout the entire rest of the protein molecule.
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iii. The parallel 3-helix
Accurate structure prediction of all 3 proteins has been most successful for
parallel J3-helices, structures in which the P-strands wind around upon each other in coil-
like fashion similar to the processive nature of an a-helix (Jenkins and Pickersgill 2001).
Although the distance between 3-strands in the primary sequence may be variable with
the insertion of large domains that project out from the stacked P-helix, many 13-helical
rungs in any given protein will be found in succession in the primary sequence. Many of
these structures, like the P22 tailspike protein and pertactin from Bordella Pertussis
contain a hydrophobic core of successive stacked nonpolar residues that runs throughout
the length of the P-helix central cavity (Betts et al. 2004, Emsley et al. 1996). An accurate
computational algorithm for P-helix prediction has been developed that takes advantage
of the processive nature of the helical rungs and the regular placement of the hydrophobic
stacked core (Bradley et al. 2001).
iv. Model f-sheet proteins
This question of how and why P-sheet proteins fold and aggregate has been
addressed by several research laboratories through analysis of small primarily 13-sheet
proteins adopting relatively simple folds and by observing kinetic and thermodynamic
trends between members of small molecule P-sheet protein families that demonstrate
high levels of structural homology. Techniques such as circular dichroism (CD), nuclear
magnetic resonance imaging (NMR), fluorescence imaging, hydrogen deuterium
exchange (H-D), and stopped-flow fluorescence (SF-flu) have provided the scientific
community with some insight into the folding pathways of 1-sheet proteins, aggregation
intermediates, and thermodynamic stability (Capaldi and Radford 1998).
b. Central questions of this thesis
In this thesis, I have investigated why the folded state of some proteins exhibit
much greater stability under physiological conditions than others. In addition, I have
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studied the process of P-sheet protein aggregation in a small model Greek key protein that
is involved in the protein deposition disorder of cataract. The protein that is the primary
focus of this thesis, human yD crystallin (HyD-Crys), remains in solution at high
concentrations for more than fifty years in most adults. In addition to deciphering how its
amino acid sequence drives it into a P-sheet fold, we hope to understand which aspects of
the sequence are important for the maintenance of this long term stability.
Despite the stability of the crystallins, as well as many other proteins, aggregated
or polymerized states form under physiological conditions. For the eye lens proteins this
aggregated state causes cataract, a major disease of the elderly. As discussed below,
considerable evidence points to partially folded or partially unfolded conformations, as
the species responsible for the self-association reactions. A second focus of this thesis
has been the identification of partially folded or partially unfolded conformers of HyD-
Crys that might be involved in aggregation reactions related to cataract.
In the sections following, I review selected aspects of P-sheet protein folding and
misfolding and the lens crystallin literature to set the context for the experimental results
described for the human y-crystallins.
b. Two-state 3-sheet protein folding
A central experimental question in the investigation of P-sheet folding, unfolding,
and misfolding, has been the nature of the partially folded intermediate in these
processes. Some of the first advances in the field of :-sheet protein folding came with
the determination that small molecule 13-sheet proteins were capable of undergoing
reversible transition from the native folded to denatured, unfolded form. A reversible
transition is two-state if does not exhibit populated folding intermediates in its conversion
from the unfolded to the folded form. When the differential fluorescence or CD of a
protein is monitored versus varying concentrations of urea or guanidinium hydrochloride,
two-state protein denaturation/renaturation transitions only show one true folded and one
true unfolded baseline.
Initially, it was believed that many proteins and their homologous family
members exhibited two-state folding. Among [-sheet proteins, these included the Src
20
homology domains from x-spectrin, Fyn tyrosine kinase Src, bovine yB crystallin, and
phosphatidylinositol-3-kinase; the fibronectin type III domains including human
fibronectin and the third domain of human tenascin; tendamistat; some members of the
interleukin family; and certain proteins classified in the intracellular lipid binding protein
family (Capaldi and Radford 1998, Jaenicke 1999).
Further work beyond simple equilibrium studies has revealed that many of
these proteins experience transient folding intermediates that are not visible in
conventional equilibrium denaturation. However, these types of two-state studies can be
of importance in determination of the Gibbs free energy of folding (Fersht 1999).
Equilibrium transitions of f-sheet molecules have been subsequently used in the
dissection of the importance of interactions in n-sheet molecules using double mutant
cycles and as a primary means of folding classification (Horovitz and Fersht 1990).
In order to successfully analyze the kinetics of folding in a model -sheet
molecule, it is necessary to extend one step beyond two-state equilibrium and to
characterize the intermediates that form in the unfolding and refolding pathways of these
molecules. Unfortunately, many intermediates are unstable, occur only transiently,
and/or are seen in only minute concentrations. We will discuss several specific examples
of model P-sheet proteins whose folding intermediates have been observed and well
characterized.
c. Intermediate stabilization by pH: IFABP
One model family system that has been extensively analyzed in P-sheet
protein studies is known as the intracellular lipid binding protein (iLBP) family. All of
these proteins are [3-barrel proteins containing solvent filled cavities that bind fatty acid
(Banaszak et al. 1993). This particular family of proteins is quite unique in that it retains
high levels of structural homology but relatively low levels of sequence homology. This
system has proved to be very important for identifying different folding pathways that
ultimately led to the same quaternary fold (Gunasekaran et al. 2001).
Dalessio and Ropson studied one member of the iLBP family, intestinal fatty
acid binding protein (IFABP), to elucidate the folding dependence of this molecule on pH
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(Dalessio and Ropson 1998). IFABP had an apparent two-state equilibrium-folding
pathway as monitored by CD, fluorescence, and absorbance studies. SF-flu studies
predicted that IFABP goes through one molten-globule-like intermediate structure in its
unfolding pathway, but a much more denatured-like folding intermediate retaining little
or no secondary structure as determined by CD in its refolding pathway. The unfolding
and refolding of IFABP were the same at all studied pH ranges except for pH 4.0.
IFABP subjected to pH 4.0 aggregated rapidly as the concentration of protein was
increased. Soluble protein formed in these conditions produced an equilibrium folding
intermediate with a fluorescence and CD signal that did not look like the signals
characteristic of the molten globule folding intermediate characterized at pH 7.0. This
transient folding structure was probably not a folding intermediate found in the normal
physiological pathway. This result is in contrast to results reviewed by Ptitsyn stating
that intermediates stabilized by low solution pH conditions are generally productive
pathway intermediates (Ptitsyn 1998).
The pH effects on IFABP refolding and unfolding by SF-Flu were then
characterized in detail (Dalessio and Ropson 1998). Kinetic folding experiments
performed at pH 6-9 showed an initial burst phase. The authors postulated this burst was
due to a global hydrophobic collapse that occurs only when the denaturant concentration
was low. Refolding experiments performed at pH 10 showed that IFABP experienced
triphasic kinetics alluding to the presence of an additional folding intermediate under
these conditions. This new intermediate may be a structure involved in the productive
folding pathway that was simply not present long enough for an accurate spectroscopic
signal to be detected at lower pH levels. The authors tentatively concluded that changing
the solution conditions in terms of pH, could in fact stabilize the transient intermediates
in [-sheet protein folding pathways normally invisible to current spectroscopic
technology.
d. Using tryptophan as a conformational probe: CRABPI
Another well characterized member of the iLBPs is cellular retinoic acid binding
protein I (CRABPI). CRABPI was initially characterized as exhibiting a two-state
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transition using urea denaturation and equilibrium analysis. CRABPI has three intrinsic
tryptophans at positions 7, 87, and 109 that provided fluorescence reporters if excited at
280 nm with emission monitored at 350 nm. These tryptophans have been used to study
the stability and folding of the molecule.
Double tryptophan mutants containing only one of the three native tryptophans
demonstrated that Trp7 and Trp87 showed significant changes in fluorescence from the
native to the unfolded state (Clark et al. 1996). Furthermore, Trp 109 experienced a
significant quenching when placed in its native environment. Later experiments
performed by Steve Eyles showed that this quenching could be at least partially reversed
by removal of Cys95 (Eyles and Gierasch 2000).
Further analysis of the tryptophan single mutants showed that wild-type CRABPI
has three definable folding phases that can be monitored using SF-flu (Clark et al. 1996).
Initially, a global hydrophobic collapse occurs characterized by all three tryptophans
experiencing a more hydrophobic environment and the formation of the only a-helix
present in the molecule. The helical structure was confirmed by NMR. A second phase
then occurs during which the environments of all of the tryptophans change indicative of
the formation of stable 3-sheet structure. It is at this point at which the hydrogen-
bonding network between the 13-strands is established. Finally, ten percent of the
CRABPI molecules were shown to exhibit a refolding alternate pathway resulting from of
cis/trans isomerization of the Leu84-Pro85 bond (Eyles and Gierasch 2000).
Proline 85 is located in what is considered the hydrophobic core region of
CRABPI. Angle restriction in the trans configuration somehow allows for the correct
alignment of surrounding residues for a global hydrophobic collapse. Free rotation of the
residue 85 q angle observed with residues like alanine, severely disturbs the folding
pathway and structural intermediates of CRABPI. These studies have now raised the
question as to whether or not hydrophobic collapse can be a contributing factor in the
folding of 3-sheet proteins that have a hydrophobic cavity. NMR studies using peptides
encoding the sequence of the loops of CRABPI have shown that they retain structure in
solution without the stabilizing effect of the entire molecule (Rotondi and Gierasch
2003). Together these data suggest that P-sheet proteins require both a global
hydrophobic collapse as well as local framework structure for proper folding.
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e. Hydrogen bond network formation: Interleukin 1-[3
To further analyze the mechanism of P-sheet formation, interleukin 1-P (IL-13)
was studied in hydrogen-deuterium exchange (H-D) experiments (Varley et al. 1993).
IL-l1 P is a small P-sheet protein with a high-resolution structure that has been
characterized by NMR. IL-1 p appears to be kinetically two-state in unfolding
experiments, but refolding studies reveal a stable intermediate molten-globule structure
may be formed that has 80-90% of the native state secondary structure (Varley et al.
1993).
Using stopped-flow far-UV CD and SF-flu of ANS binding and tryptophan
fluorescence, the refolding kinetics of IL-1p were characterized. In combination, by
reporting on different phenomenon, these two techniques showed that three refolding
intermediates of IL- 1 exist.
CD experiments showed that all secondary structure was fully formed at 6
seconds. The fluorescence data, however, demonstrated an initial burst phase faster than
6 seconds corresponding to a hydrophobic collapse and a subsequent slow folding
process that continued for over 20 minutes. The discrepancies in the two data sets
suggest that secondary structure formation is separable from initial folding collapse in IL-
113 and the final hydrophobic environment of tryptophan is not fully achieved until the
slow orientation of small pieces of 3-sheet occurs.
The kinetics of refolding of IL-1 were then characterized with quenched-flow H-
D exchange experiments with two-dimensional H-' 5N correlation spectroscopy to
monitor the rate of stable backbone amide hydrogen bonding of the protein (Varley et al.
1993). By observing amide peak protection versus incubation time, they were able to see
that no stable hydrogen bonds representative of 1-sheet formation were present until 1
second of refolding had passed. A preliminary hydrogen-bonding system was observed
at 1 second although the hydrogen-bonding network for the protein did not fully form
until 25 seconds. It was further demonstrated that all the early forming 1-sheets were in
areas of the molecule that interact with a-helices or other types of early folding structures
independent of other 1-sheets.
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The initial folding states seen with fluorescence and CD were, therefore, not a
result of the formation of true P-sheets, because these structures require the formation of
hydrogen bonds that would be observable in the H-D exchange experiments.
Fluorescence and CD data perhaps allude to an early forming molten globule folding
form of IL- 1 3 that forms isolated unstable 1-strands or 3-like structures. These data
demonstrate true 1-sheet formation and inter-strand alignment of these types of
secondary structures are perhaps the last features that form in the small molecule 1-sheet
protein folding pathways.
f. Aggregation prone intermediates: IL- 1
Scientific attention has moved from mechanistic studies of folding and refolding
to determining the mechanisms of off-pathway aggregation processes. In the past few
years, studies have determined that the incorrect folding of some naturally occurring
proteins normally present in native a-helical conformations to primarily 5-sheet
molecules may be implicated in the formation of harmful aggregation intermediates
(Prusiner 2000). Some off-pathway 1-sheet intermediates self-associate and result in the
formation of amyloidogenic plaques and ultimately untimely death in higher organisms.
For this reason, it is useful to study the aggregation process of known small 1-sheet
molecules to try and establish folding trends of 3-sheet proteins.
The effects of single residue mutations on aggregation of IL-1 1 during the folding
process were studied by Finke et al. (2000). Ninety percent of the wild-type IL- 13
produced in E. Coli expression systems was found in the soluble portion of the
centrifuged cellular lysate. Several different point mutations have been isolated and
characterized in this protein that cause over 90% of the protein expressed in E. Coli to be
in the form of inclusion bodies. Mutation of a charged lysine residue present in the
native protein in a flexible loop at position 97 to a hydrophobic isoleucine resulted in the
production of a folded protein that was thermodynamically more stable than the wild-type
monomer form, but that was expressed primarily in inclusion bodies.This suggested that
the mutation was acting on a folding intermediate or at the junction of productive folding
and off-pathway aggregation. K97I appears to have the same slow folding step, the same
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synthesis rate on the ribosome, and the same level of chaperone interaction and assistance
as wild-type IL-1 P. Protein extracted from in vitro aggregates of K97I and in vivo
inclusion bodies have demonstrated both systems produce insoluble proteins with nearly
identical secondary structures as observed with Fourier transfer infrared spectroscopy.
Using SF-flu to measure kinetic refolding characteristics of IL-1 B showed that
high protein concentrations changed the early events in refolding of the molecule (Finke
2000). As the concentration of K97I was increased, the transition from the unfolded to
intermediate state was found to be the only folding step dependent on concentration.
Similarly, stopped-flow light scattering demonstrated that whereas wild-type IL-1 B
experienced no scattering no matter what concentration of protein was tested, K97I light
scattering was present in samples of greater than 18 gM. It was, therefore, hypothesized
that aggregation was occurring in the unfolded to intermediate transition.
The self-association process of K97I most likely occurred between unfolded
molecules under native conditions first experienced when initial refolding buffer was
injected in the GdnHCl solution. The authors proposed a scheme for the possible
aggregation mechanism of K97I. The proposed model relies on a nucleation mechanism
for aggregation based on the fact that a critical protein concentration is needed for protein
self-association. The hypothesis states that the flexible loop encompassing residues 86-
99 represented an isolated "hydrophobic micro-domain" in the early peptide sampling
process. The substitution of the hydrophobic residue isoleucine for the charged lysine,
caused an increase in the hydrophobic surface area of the micro-domain. The
hydrophobic area could more efficiently form and thus can more effectively interact with
other exposed hydrophobic loops. The continued association of the hydrophobic regions
over time could eventually lead to aggregation. Lysine 97 present in wild-type IL-1 [ had
a strong charge that destabilized the hydrophobic packing of the overall molecule
preventing aggregation.
Such aggregation intermediates in P-sheet proteins stabilized by micro-domain
packing may represent possible a therapeutic target for prevention of self-association
protein folding diseases.
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B. -SHEET PROTEINS INSIDE THE LIVING LENS
The human lens contains a unique class of proteins that are important for both
generalized protein folding studies and for their involvement in aggregation and cataract.
The protein in the lens may be present at concentrations at high as 700 mg/mL and
maintains a short-range order that allows light to be correctly diffracted and focused on
the retina for proper vision (Figure 1-1) (Delaye and Tardieu 1983, Jaenicke 1999). The
proteins in the lens must maintain high stability over the human lifetime as there is no
protein turnover in this organ. The ubiquitous crystallins may be separated into two
classes, a-crystallins and 5y-crystallins.
i. The chaperone: a-crystallin
The two identified human ca-crystallins are aA and aB crystallin, both of which
are thought to perform chaperone-like functions in the human lens. The native
conformation of lens a-crystallin appears to have a 3:1 stoichiometric ratio of aA to aB
crystallin (Horwitz et al. 1999). Although the crystal structures of neither of the a-
crystallins have been solved directly, light scattering and mass spectroscopy studies have
shown that these proteins self-associate in vitro to form multimeric species composed of
anywhere from 24 to 33 protein subunits (Aquilina et al. 2003).
Electron microscopy has shown that the multimers are spherical with hollow
centers that are thought to bind destabilized or partially unfolded protein species
nonspecifically (Haley et al. 2000). In vitro studies have shown that the presence of a-
crystallin may inhibit aggregation of not only the Py-crystallins, but other aggregation-
prone proteins such as the serpins and abrin (Reddy et al. 2002, Devlin et al. 2003).
The association of the a-crystallin spherical complex with a destabilized protein
may prevent further self-association and aggregation. It is unclear whether the a-
crystallins are present in the high molecular weight protein removed from cataractous
lenses simply because they have associated with the aggregating material in a chaperone-
related role or whether destabilization and/or mutation of the a-crystallin itself can
initiate cataract formation (Clark and Muchowski 2000, Horwitz 2000, MacRae 2000).
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Most recently, studies of normal and cataractous lenses showed that certain
covalent damage and specific residue racemization in the a-crystallins are the same in
both the HMW and LMW fractions in both lens types indicating that covalent damages in
a-crystallin are unlikely the causative agent of cataract (Takemoto and Boyle 1998, Fujii
et al. 2003).
ii. The f/y-crystallins
The [Py-crystallins are primarily structural proteins of the lens (Jaenicke 1999).
The [y-crystallins found in the human lens are PA1 crystallin, PA3 crystallin, PA4
crystallin, [B 1 crystallin, PB2 crystallin, yC crystallin, yD crystallin, and yS crystallin.
Sequence alignment of both DNA and amino acid sequence shows that the p-crystallin
family includes the two-domain protein, protein S of Myxococcus xanthus (Jaenicke
1999). The only known single domain py-crystallin homologue is the dormant protein
spherulin S3a from Physarum polycephalum (Jaenicke 1999).
The 3By-crystallins are made up of two highly homologous domains that appear to
be the result of gene duplication and fusion during evolution (Lubsen et al. 1988). Each
domain is primarily P-sheet and is composed of two Greek keys separated by a linker of
variable length. The P-crystallins have approximately 30% sequence similarity to the y-
crystallins. The ,-crystallins are oligomeric in solution while the y-crystallins are
monomeric and the 3-crystallins contain N- and C-terminal extensions absent in the y-
crystallins (Jaenicke et al. 1999).
The 3-crystallins have a connecting peptide between the N- and C-terminal
domains that is found in an extended conformation in the crystal structure, whereas the
linker peptide in the y-crystallins has a central glycine that adopts a V-like conformation
(Blundell et al. 1993, Bax et al. 1990, Najmundin et al. 1993). The 3y-crystallins have
been implicated in the development of juvenile onset cataracts and these proteins are
primary components of mature onset cataracts.
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Cornea
Lens
Aqueous Humor
Figure 1-1
Retina
Vitreous Humor
Schematic diagram of the human eye. The purple lines represent the passage of light
through the lens and its refraction onto the retina. The different regions of the eye are
labeled.
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iii. Folding of the py-crystallins: small fp-sheet proteins important in cataract
The y-crystallins have been studied for their role in cataract formation and for
their importance as small model 3-sheet proteins. The Greek key fold has a compact
hydrophobic core at the center with highly organized, structural loops at either end. The
py-crystallins contain four Greek key motifs with two in each domain. These proteins
have remarkable stability presumably reflecting their functional requirement to remain
soluble at high concentration for long periods of time in the eye lens (Jaenicke 1999).
The P-sheet and Greek key propensities of the y-crystallins have been analyzed in an
attempt to determine how and why P-sheet proteins fold and how the Greek key structure
of these proteins is involved in protein stability. I will discuss several thorough studies of
specific y-crystallins not directly covered in later chapters.
a. Stability differences between P- and y-crystallins
To determine the overall stability of the y-crystallins, the difference in resistance
to GdnHCl denaturation by the py-crystallins was assessed spectroscopically by
comparing the unfolding characteristics of human BB2 crystallin to human yC crystallin
(Fu and Liang 2002). Size exclusion chromatography indicated that intramolecular
contacts between PB2 crystallin dimers were disrupted at very low concentration of
GdnHCl. The thermodynamic stability of PfB2 crystallin monomer was higher than that
of yC crystallin monomer when unfolding was measured with absorbance at 235 nm,
fluorescence at 320 nm, and far-UV at 223 nm. Both proteins showed equilibrium
transitions that were best fit to a three-state model demonstrating that both PB2 and yC
crystallin unfolded via a partially denatured intermediate.
b. Assessing the importance of interface interactions
The intermediate observed in these studies is likely a structure with one domain
folded and one domain in native-like conformation. Given the two-domain structure of
the py-crystallins, it seems equally likely that the interface interactions between the
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individual domains are important in Py-crystallin stability. Several research laboratories
have attempted to resolve the structure of the partially unfolded intermediate and assess
the contribution of the domain interface to the overall stability of the py-crystallins
(Jaenicke 1999).
Isolated N- and C-terminal domains of Protein S were constructed and studied to
determine whether the domain interface was important to maintaining the stability of this
py-crystallin as well (Wenk et al. 1999). Protein S is a calcium binding two-domain pfy-
crystallin that has 172 amino acids (Wistow et al. 1985). Native Protein S showed
independent domain folding where the N-terminal domain is less stable than the C-
terminal domain. The stability and cooperativity of the intact molecule increased
significantly in the presence of calcium although the stability of the N-terminal isolated
domain was unaffected by the cation. Protein S showed a biphasic transition when
denatured in urea at pH 2.0 while the isolated domains each show two-state transitions
(Wenk and Mayr 1998, Wenk et al. 1999). Furthermore the midpoint of the denaturation
transition for the isolated N- and C-terminal domains were located at lower
concentrations of urea than wild type indicating a destabilization of the truncated
proteins. The isolated domains did not exhibit any propensity to form pseudo-native
molecules when mixed together in solution. From these studies, domain interactions
appear to be important to the stability of Protein S (Wenk et al. 1999).
The importance of the domain interaction in y-crystallin stabilization was further
assessed in yB crystallin from calf eye lens. When denatured in urea at pH 2.0, an
unfolding intermediate was stabilized as shown by a biphasic equilibrium transition
(Rudolph et al. 1990). Kinetic experiments revealed that the intermediate retained a
similar structure during both unfolding and refolding analysis in which the C-terminal
domain was unstructured and the N-terminal domain was in a rigid conformation.
Construction of the isolated domains of yB revealed that the N-terminal domain was
more resistant to GdnHCl denaturation than the C-terminal domain (Mayr et al. 1997).
Furthermore, similar to Protein S, the individual domain constructs of bovine yB
crystallin did not associate to form a pseudo-native molecule in solution. Formation of
the interface was necessary to maintain native-like structure in the C-terminal domain.
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c. Oligomerization of y-crystallins
The By-crystallins have also been studied as model P-sheet proteins prone to
multimerization. The stability and aggregation characteristics of the 03-crystallins were
studied using temperature and urea induced unfolding experiments (Bateman et al. 2001).
Oligomerization and precipitation of human P-crystallins were observed at high
temperature. When hetero-oligomers were constructed by subunit exchange, P3A was
stabilized when it oligomerized with PB 1 crystallin. These results suggest that the
formation of hetero-oligomers of different subunits may add a further level of
stabilization to the -crystallins.
The N- and C-terminal extensions of the oligomeric f3-crystallins are thought be
involved in protein multimerization (Norledge et al. 1996). The energetics of the domain
to domain interactions were studied in recombinant mouse PA3 and PB2 crystallin by
Sergeev et al. (2004). Both proteins were found in reversible monomer-dimer
equilibrium from 5-35°C. The amount of time the two P-crystallins spent in the dimer
state increased significantly at elevated temperatures. The overall entropy and enthalpy
of binding in recombinant proteins with truncated N-termini increased as compared to
wild-type. It is possible that post-translational truncations of f-crystallins in the eye lens
make the protein more susceptible to association, aggregation, and cataract.
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C. CATARACT AS A PROTEIN DEPOSITION DISEASE
Mature onset cataracts affect nearly 15% of the US population over 40 years of
age and are the leading cause of blindness worldwide (NEI 2002). Pathological studies
of cataractous lenses have revealed that cataracts are composed of protein aggregates that
precipitate or polymerize in the lens region of the eye (Oyster 1999).
The aggregates removed from patients with mature onset cataracts are quite
amorphous by light microscopy and do not appear to have distinct structures or sizes.
The precipitation may occur anywhere in the lens from the nucleus to the dividing
epithelial cells and can begin at any point in life although the prevalence of mature onset
cataracts in the population increases sharply with age. The aggregated material extracted
from aged lenses is composed of a variety of proteins most of which belong to the
crystallin family rather than one dominant species (Hanson et al. 2000).
There are many covalent modifications in the high molecular weight (HMW)
insoluble protein fraction of aged lenses including deamidations, methylations,
acetylations, carbamylations, glycations, truncations, cysteine and methionine oxidations,
and tryptophan ring cleavages (Hanson et al. 1998, Lin et al. 1998, Ma et al. 1998,
Hanson et al. 2000, Clovis and Garland 2002, Lapko et al. 2002, Srivastava and
Srivastava 2003, Srivastava et al. 2004). The prevalence of these modifications is
markedly increased in the HMW material with respect to the low molecular weight
(LMW) fractions. It is still unclear whether these modifications are the causative agents
of the cataracts or occur after the protein aggregates. It is possible, however, that changes
such as these locally or globally destabilize the polypeptide structure making it more
susceptible to aggregation. For all these reasons, the mechanism of mature onset
cataractogenesis is still unknown.
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D. MECHANISMS OF PROTEIN AGGREGATION
i. Disordered protein polymerization
The insoluble, nonfibrous nature of the protein removed from aged cataractous
lenses, makes cataract a possible candidate for non-specific protein aggregation (Figure
1-2). In this model, regions of several molecules would associate at random and
eventually precipitate from solution.
Aggregation is rarely a random process in situations not affected by heat
destabilization. Oftentimes, protein self association occurs via specific native or non-
native interactions. Lysozyme, in particular, may undergo non-specific protein
aggregation under certain conditions, but it may also form specific amyloidogenic
interactions under similar conditions (Fischer et al. 1993, Cao et al. 2004).
ii. Ordered protein polymerization
Many diseases are now known to be caused by protein misfolding and
aggregation. Afflictions such as Alzheimer's disease (AD), Creutzfeldt-Jakob's Disease,
and Parkinson's disease (PD) are thought to be directly caused by the misfolding and
aggregation of proteins in the brain (Caughey and Lansbury 2003). Although the exact
mechanism of axon death and dementia are unknown, all of these diseases have distinct
ordered protein aggregates that accumulate in the brain of afflicted patients. Despite the
unstructured nature of the mature onset cataract observed in the light microscope, it
seems reasonable that the species that initiates aggregate formation is composed of
ordered inter-protein associations. Furthermore, the eye lens is packed with crystallins in
their native states, so cataract is likely to form from native-like or partially unfolded
proteins. Such species are likely to be sufficiently structured to yield ordered
polymerization reactions.
Several studies have been performed on crystallins demonstrating these proteins
are capable of ordered aggregation. Amyloid fibers can be produced from P- and y-
crystallins when they are refolded out of acidic conditions (Meehan et al. 2004). The
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crystallins also bind thioflavin T and Congo red and show birefringence (Fredrickse
2000, Sandilands et al. 2002). These dyes are used to identify ordered P-sheet structures
and amyloid. Atomic force microscopy of human yD crystallin shows formation of
distinct twisted fibrils that collapse to form fiber-like aggregates (Kosinski-Collins and
King 2003). It is likely that aggregation of a few protein molecules in an organized self-
association process may seed the subsequent aggregation of other polypeptides thus
facilitating cataract formation.
Ordered aggregation can occur through native-like or nonnative interactions.
Native-like aggregation mechanisms include domain swapping and loop-sheet insertion.
Nonnative interactions that cause aggregation include the prion diseases, amyloid
formation, and self-association caused by mutation.
a. Aggregation caused by mutation and association of native-like states
Sickle cell anemia is caused by a specific glutamine to valine mutation at position
six of hemoglobin (Ingram 1956). This mutation substitutes a surface exposed polar
amino acid with a hydrophobic residue. The mutated valine associates with an adjacent
hemoglobin molecule at Phe85 and Leu88 (Bihoreau 1992). Because the native form of
hemoglobin has four subunits, there are two valines that provide points of contact for
other proteins on each side of the molecule. If nearby mutated proteins associate in a
staggered network, multiple molecules can continue to associate via this valine-
hydrophobic connection forming long extended, fiber-like threads (Figure 1-3). Under
conditions of low oxygen, the long thin fibers grow across the red blood cell and distort
the cell morphology to a "sickle-like" shape.
Aggregation of the native-like state occurring due to mutation of the crystallin
proteins has been implicated in juvenile onset cataracts. Numerous heritable mutations in
chromosome 22 in the human yD crystallin and human yC crystallin genes are involved
in the pathogenesis of juvenile cataract (Heon et al. 1999; Kmoch et al. 2000, Ren et al.
2000, Santhiya et al. 2002, Nandrot, et al. 2003, Shentu et al. 2004).
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Figure 1-2
Schematic representation of one possible mechanism of disordered aggregation.
Unfolded proteins close to one another in solution associate via non-native contacts (gray
lines). The contacts may continue throughout many monomers creating an polymerized
"mat" of protein.
Altered Hemoglobin
Tetramer
Association of Mutated
Hemoglobin Tetramers
Figure 1-3
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Hemoglobin Fibers
Schematic representation of hemoglobin tetramer association in sickle-cell anemia. The
hemoglobin tetramers associate via a non-native valine which forms a nonpolar
interaction with a hydrophobic pocket in another region of the molecule. The
polymerization continues through multiple tetramer eventually forming a long, thin fiber.
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An arginine to cysteine mutation at position 114 in HyD-Crys exposes a cysteine
sulfur on the edge of domain II of the molecule. In vitro studies on the mutated protein
showed that an intermolecular disulfide bond formed between Cys 114 of one molecule
and the natively solvent exposed Cys 110 of an adjacent molecule (Stephan et al. 1999,
Pande et al. 2000). High molecular weight oligomers were formed that retained the
molecule's overall native state, but were covalently bonded through this non-native
disulfide bonding network.
Two additional unique mutations in HyD-Crys are the R38H mutation that results
aculeiform juvenile cataracts and the R36S mutation that causes congenital juvenile
cataracts (Heon et al. 1999). In the human eye, these mutations cause the protein to
crystallize and fall out of solution. Studies performed on the R38H and R36S mutants
showed crystals formed that retained native-like structure in vitro but formed strong
intermolecular association tendencies not observed in the wild-type protein (Pande et al.
2001).
Although the aforementioned amino acid substitutions are caused by hereditary
DNA mutations, the underlying mechanism of ordered protein aggregation in these
processes may be applicable to mature onset cataracts as well. Crystallin proteins
removed from old cataractous lenses contain many covalent modifications. It is still
unclear whether these modifications destabilize the protein making it more prone to
cataract or if covalent damage is accumulated after the precipitates form. It is possible,
however, that deamidation, peptide bond cleavage, methylation, carbamylation, aromatic
ring opening, and even cysteine or methionine oxidation caused by one of the many
oxidative stresses present in the lens may accumulate in the crystallins disrupting protein
structure. As demonstrated in the both sickle cell anemia and the juvenile onset cataracts,
one exposed hydrophobic or cysteine residue can act as an interaction interface for
oligomer formation.
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b. Domain Swapping
A candidate mechanism for aggregation of many proteins is domain swapping (Liu
and Eisenberg 2002). In these polymerization reactions, native inter-domain interactions
in a monomer are replaced with interactions between folded conformational regions of
multiple polypeptide chains (Figure 1-4). In most cases the swapped structure had been
identified unexpectedly in the crystal form or the protein. The kinetic process has only
been observed and studied experimentally in a limited number of cases.
One protein "swaps out" an independently folded unit of its structure for the same
folding unit of another protein of identical sequence. Domain swapping may involve
isolated pieces of secondary structure such as one P-strand or one a-helix or may involve
the swapping or an entire domain of the protein. Because domain swapping involves
proteins of the same linear sequence with little or no 3-dimensional remodeling of the
folded secondary structure, the intermolecular interactions formed are native-like, often
as strong as the monomer interactions, and cannot be visualized using techniques that
monitor loss of secondary structure like circular dichroism.
Domain swapping can occur in closed conformation in which a specific number of
molecules swap conformational units resulting in a circularized protein multimer with no
free unpartnered domains. Alternatively, domain swapping has been hypothesized to
occur in infinitum producing an open-ended conformation with unpartnered domains on
either end of the growing chain. It is in this open-conformation that polymerization and
aggregation of proteins is thought to occur (Liu and Eisenberg 2002, Rousseau et al.
2003).
The first protein to be crystallized in a domain swapped conformation was diphtheria
toxin (Bennett et al. 1994). Domain swapping produces either dimers or trimers in RNase
A that involve swapping of either the N- or C-terminal portions of the molecule,
indicating that one protein may have multiple domain swapped conformations (Liu et al.
2001, Liu et al. 2002).
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Native
Protein Higher Order Oligomers
Dissociated Domain
Interface Conformation
Figure 1-4
Schematic representation of domain swapping. Intramolecular contacts are broken
between two individual domains in the protein and are replaced by native-like
intermolecular domain contacts. The domain swapping reaction may occur between
several protein molecules and may form higher order oligomers.
Figure 1-5
Ribbon diagram of ~B2 crystallin in its crystallized domain swapped conformation (Bax
et al. 1990).
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A functional role for domain swapping was first identified in Glyoxalase I. This
protein is enzymatically active in the domain swapped dimeric state, but its activity is
reduced when it is found in a less stable monomeric state (SaintJean et al. 1998).
In vitro studies have allowed domain swapping to become appreciated as a viable
mechanism for aggregation. The rate at which suc 1 aggregated during heating was
correlated with the rate at which the protein was able to domain swap (Rousseau et al.
2001). In addition, during refolding of several proteins including suc 1, the maltose
binding protein, and E. Coli tryptophanase, domain swapping is thought to occur as part
of either on- or off-pathway conformational states (Silow et al. 1999, Ganesh et al. 2001,
London et al. 1974). Finally, and perhaps most strikingly, protein engineering has
produced a three-helix bundle protein that was capable of producing not only domain
swapped dimers, but higher order oligomeric structures as well (Liu et al. 2001).
Because the py-crystallins are made up of two highly homologous domains, they are a
likely candidate for domain swapping. In fact, whereas the y-crystallins are monomeric
in solution, the [3-crystallins are dimeric and are composed of two domain swapped
chains (Figure 1-5) (Bax et al. 1990). Deamidation and truncation in 3B1 crystallin cause
elongation of the dimer and modifications of the P-crystallins tend to cause association of
3B2 crystallin with the modified protein (Lampi et al. 2001, Zhang et al. 2003). Perhaps
a destabilization in the domain interface causes the native intramolecular interface to
dissociate and become more likely to domain swap intermolecularly. A domain swapped
core of the crystallins could act as a nucleus for further aggregation and, ultimately,
cataract formation.
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b. Loop-sheet insertion
The serine protease inhibitors or serpins are a class of proteins with distinct structural
characteristics that control function. Serpins are composed of a central P-sheet structure
with a highly flexible, unstructured, sixteen residue loop. During serpin function, the
reactive loop is cleaved in the metastable state which has a melting temperature (Tm) of
60°C and the cleaved strand may become incorporated into the P-sheet forming a highly
stable structure with a Tm of greater than 100°C (Carrell and Gooptu 1998).
One well studied serpin is known as al-antitrypsin. In the active state, al-antitrypsin
has a P-sheet made up of five antiparallel P-strands with a surrounding flexible loop. The
loop is considered extremely flexible, because its 3-dimensional structure varies based on
the pH at which it is crystallized (Ryu et al. 1996, Kim et al. 2001). When the loop is
cleaved by trypsin, it inserts itself into the P-sheet forming a six stranded highly stable,
but inactive protein.
Normal, functional, loop-sheet insertion occurs intramolecularly, however, it is
possible that the cleaved strand of one protein may insert into an adjacent sheet of
another protein molecule (Figure 1-6). The polymerization process may continue
between several protein molecules and eventually the chain becomes long enough
causing the polymer to fall out of solution (Banzon and Kelly 1992, Carrell et al. 1994,
Huntingtin et al. 1999).
Intermolecular loop-sheet insertion has been observed with many serpins and the
subsequent serpin deficiency has been identified as the cause of many diseases (Figure 1-
7). For example, al-antichymotrypsin deficiency results in liver damage, al-antitrypsin
deficiency causes cirrhosis and emphysema, antithrombin deficiency results in
thrombosis, and Cl-inhibitor deficiency results in angioedema (Bruce et al. 1994, Sifers
1995).
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Figure 1-6
Schematic representation of loop-sheet insertion. In this mechanism, a ~-strand from one
protein is disrupted from its intramolecular native state and becomes incorporated into a
nearby protein via native-like interactions.
Figure 1-7
Ribbon structure of a cleaved a I-antitrypsin polymer. The intermolecular loop-sheet
insertions of ~-strands are shown in black (Huntington et al. 1999).
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The structure of the py-crystallins is quite high in P-sheet content. Each domain is
composed of two Greek key motifs. In cataracts removed from aged lenses, one major
covalent modification is peptide bond cleavage. For human yD crystallin, a premature
truncation at Trp156 has recently been identified as a causative agent of juvenile onset
cataracts (Santhiya et al. 2002). One could imagine that peptide backbone cleavage or
simply tertiary structure destabilization could produce a free strand with the potential of
becoming incorporated into another domain. If this inter-molecular P-sheet is stable, it
has the potential to be propagated over several molecules thus producing a large
molecular weight species prone to aggregation.
In addition, a-crystallin is known to bind the py-crystallins both in vitro and in
vivo. Recently, Devlin et al. demonstrated that a-crystallin was able to prevent the
nucleation-dependent aggregation of al-antitrypsin and al-antichymotrypsin (2003).
Perhaps the loop-sheet insertion self-association reaction of these two serpins presents a
binding epitope for a-crystallin that is similar to the binding region formed in the
polymerization of the fly-crystallins.
c. Amyloidosis
Many human proteins are capable of forming amyloid-like fibrils in vivo and
causing a variety of diseases many of which are characterized by neurodegeneration
(Kelly 1996). Some of the most well understood amyloid forming polypeptides include
transthyretin (TTR) which causes senile systemic amyloidosis, P2-microglobin which
causes dialysis and hereditary renal amyloidosis, lysozyme which causes autosomal
hereditary amyloidosis, and the A,3-peptide which may cause AD (Saraiva 2001, Inuoe et
al. 1997, Pepys et al. 1993). In the amyloidogenic diseases, native protein conformation
is altered resulting in the formation of a protein structure capable of self-associating into
a primarily P-sheet fiber structure in which the P-strands are perpendicular to the long
axis of the fibril (Figure 1-8) (Sipe 1994).
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Amyloid proteins bind thioflavin T and show Congo red birefringence. The fiber-
like structure of amyloid may be anywhere from 60-100 A in width and may be branched
or unbranched. Oftentimes, the fibrils are twisted and demonstrate regular periodicity
visible in TEM and AFM images (Caughey and Lansbury 2003).
Transthyretin is a protein that undergoes an acid-induced conformational change
in vitro. Under these conditions, an intermediate is formed that is capable of
polymerizing into amyloid fibrils (Figure 1-9) (Colon and Kelly 1991, Colon and Kelly
1992). TTR is normally found in the tetrameric state at pH 7.5. When the pH is reduced
to 5, the tetramer dissociates into monomers that have both secondary and tertiary
structure, but do not have exposed hydrophobic surfaces. The pH-induced monomers are
thought to be the intermediates in amyloid formation (Lai et al. 1996). Interestingly,
these monomers are not detected in a mutant of TTR, T 19M, known to be resistant to
amyloid fibril formation (McCutchsen et al. 1995).
Perhaps the most prominent of the amyloid-forming polypeptides is the Ap-
peptide because of its involvement in AD. The amyloid precursor protein (APP), a
membrane protein of unknown function, is cleaved in the cell by presenilins and a
peptide of 40 or 42 amino acids is released. When released from the membrane, the A3-
40 or AP-42 peptides are converted to amyloidogenic intermediates with strong
propensities to form P-sheets. When the concentration of the AP-40 or AP-42 peptides is
high enough, atomic force microscopy has revealed a nucleation-dependent
polymerization mechanism involving a protofibril intermediate which then converts to a
twisted amyloid fiber (Harper et al. 1997b, Harper et al. 1999). The protofibrils are
approximately 40% of the width of the fibers and are usually unbranched. The protofibril
to fiber transition may be accelerated by addition of fiber nuclei seeding units (Harper et
al. 1997a).
Recent studies have identified other protein structures in the amyloidogenic
pathway (Kayed et al. 2003). Many fiber-forming proteins may adopt a conformation
consisting of a "ring" of monomers linked together via an unknown association
mechanism.
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Figure 1-8
Schematic representation of disordered amyloid formation. In amyloidosis, the native
protein changes conformation to an intermediate conformation. The intermediate can
then polymerize into amyloid fibers or pores.
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Figure 1-9
Schematic representation of TTR aggregation (Colon and Kelly 1991). As the pH of the
solution is lowered an amyloidogenic intermediate forms that is capable of becoming
fibers or pores.
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The pore-like species appear independently from the amyloid fibers and are
thought to be an off-pathway polymerized state. The oligomeric, amyloid pores have
structures that are similar to bacterial cytolytic P-barrel pore-forming toxins and thus are
believed to increase membrane permeability (Hotze et al. 2002). Historically, the
amyloidogenic fiber aggregates were thought to be the toxic species in amyloidogenic
disease. However, protofibrils and small oligomeric aggregates of transthyretin (TTR),
Cu/Zn superoxide dismutase 1 (SOD 1), amyloid-P protein (A3) and a-synuclein all cause
cellular toxicity reminiscent of their respective diseases, systemic amyloidosis, familial
amyotrophic lateral sclerosis (FALS), Alzheimer's disease (AD), and Parkinson's disease
(PD) (Caughey and Lansbury 2003).
Experiments performed on TTR have shown that small oligomeric species cause
apoptosis of IMR-32 cells in culture (Reixach et al. 2004). Aggregates of TTR were
filtered using size exclusion chromatography and only species of less than 100 KDa
induced cell death. The cytotoxic species is thought to be in either a monomeric or a
nonnative hexameric state.
The cellular conformation of a-synuclein is natively unfolded and the protein has
an undetermined physiological function (Jensen et al. 1998, Lotharius and Brundin 2002).
This protein undergoes a polymerization pathway that proceeds from small spherical
protofibrils to long fiber filaments as observed in TEM images (Caughey and Lansbury
2002). The rate of formation of the pore-like oligomers is accelerated by mutations in a-
synuclein known to be associated with PD. Furthermore the PD oligomer has significant
membrane-binding capability that may be related to the disease (Conway et al. 1998).
These circular oligomers of a-synuclein have the ability to disrupt synthetic vesicles and
are now considered the cytotoxic cellular species (Volles et al. 2001, Volles and
Lansbury 2002).
The mechanism of neuronal cell death in AD is thought to be caused by a change
in membrane ion permeability by A3 protofibrils (Kawahara and Kuroda 2000).
Mixtures of wild-type and pathogenic forms of AP-40 form protofibrils and amyloid
pores in vitro (Lashuel et al. 2003). TEM of the aggregating protein revealed that several
different AP polymerized structures formed including small compact circular particles of
4-5 nm in size, pore-like protofibrils, large spherical aggregates of 18-25 nm in diameter,
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as well as fibril and fibrous species. The circular oligomers may create amyloid pores
that destabilize membrane permeability (Caughey and Lansbury 2003).
SOD 1 undergoes a polymerization process that is slightly different to those
described for AP and a-synuclein. Mutants of SOD1 implicated in familial amyotrophic
FALS aggregate under oxidizing conditions, but the aggregates are not amyloid in either
their appearance or ability to bind Congo red or thioflavin T (Rakhit et al. 2002). Post-
mortem studies transgenic mice expressing SOD1 variants observed in FALS have
identified fragmented Golgi apparatus reminiscent of insufficient energy production by
cellular mitochondria (Stieber et al. 2004). Pore-like oligomeric species have recently
been identified during in vitro studies that may interact with and disrupt the
mitochondrial membranes in FALS neuronal cells (Chung et al. 2003).
Dobson and his coworkers have shown that many proteins, including the
crystallins, are capable of undergoing a conformational change that produces amyloid in
vitro (Meehan et al. 2004). This suggests that under the right conditions, the p3y-
crystallins could undergo a structural rearrangement in the lens to form an intermediate
capable of polymerizing into an amyloid fiber.
Specifically, HyD-Crys has been shown to form both amyloid and non-amyloid
fibers in vitro (Meehan et al. 2004, Kosinski-Collins and King 2003). Preliminary AFM
studies have demonstrated that small circular structures may form during aggregation in
vitro as well (M. S. Kosinski-Collins, D. J. Solis, A. Belcher, and J. A. King, unpublished
results) (Appendix E). We do not know whether any of these species may form in the
lens or if a change in lens cell permeability is important in cataract. In addition, we have
no idea whether or not amyloid fiber or pore formation actually happens in the eye, but
an amyloid fiber or oligomeric seed may very well be the core of the cataractous material
removed from aged lenses.
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d. Prion diseases
The prion diseases are a distinct class of amyloid-forming molecules. Prion
diseases are characterized by a conformational change from one form of a protein to
another and result in the accumulation of fiber-like structure that can bind Thioflavin T
and show Congo red birefringence. In the transmissible spongiform encephalopathies
(TSE) such as kuru and Creutzfeldt's Jakob's disease, the cellular prion protein (PrP)
changes from an a-helical state to a primarily -sheet scrapie species (PrPS c) (Pan et al.
1993, Safar et al. 1993, Baldwin et al. 1994, Lansbury 1995, Nguyen et al. 1995, Zhang
et al. 1995). The cellular function for PrP is not currently known. PrPS c is a protein-only
infectious particle that may convert PrP to the scrapie state and thus makes the disease
transmissible when PrPS c protein is transferred from an infected to a healthy individual.
There is a distinct species barrier in the infectivity of prion diseases.
Cohen and Prusiner have hypothesized that the amyloid structure of the
aggregated PrPS c is a trimer composed of three right-handed parallel P-helices. Folding
studies on the P22 tailspike protein, a polypeptide adopting a parallel P-helix fold, have
shown that this structure is prone to self-association and aggregation during folding and
that the resulting aggregate is resistant to SDS and temperature denaturation (King et al.
1996). The native structure of the Py-crystallins is composed of antiparallel 3-sheets.
One could imagine a 3-dimensional rearrangement of the py-crystallins that formed a P-
helical structure similar to that observed with PrP.
Although it is unlikely that cataract is a self-propagating prion-like disorder, it is
important to remember that once an aggregating nucleus forms, it provides a sink for any
other proteins that become unfolded or mutated due to environmental stresses. Because
of the lack of protein turnover in the eye, at some rate, the naturally present proteins are
being modified through oxidation by atmospheric oxygen, heat, and electromagnetic light
(Sliney 2002). If a polymerized "seeding" unit is formed in the eye that contains exposed
hydrophobics, it may recruit any other nearby proteins as they become disrupted before
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the natural degradation and chaperoning machinery of the lens can stop or impede the
aggregation process.
One way in which amyloid may form is via a domain swapping mechanism (Liu
and Eisenberg 2002). Crystallography and NMR reveal that two proteins capable of
amyloid formation, the human prion protein and human cystatin C, may domain swap
and form fibers in vitro (Knaus et al. 2002, Janowski et al. 2001). It is possible that the
domain-swapped species may either directly assemble into amyloid. Alternatively,
polymerization of PrP and cystatin C may involve an intermediate common to the domain
swapping and amyloid formation pathways.
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CHAPTER II: CHARACTERIZING THE UNFOLDING, REFOLDING, AND
AGGREGATION OF HUMAN yD CRYSTALLIN, AN EYE LENS PROTEIN
IMPLICATED IN CATARACT FORMATION
A. INTRODUCTION
Human age-onset cataracts affect nearly 50% of the world's population and are
the leading cause of blindness worldwide (Clark 1994). Although cataracts are treatable,
this treatment is invasive, expensive, and is performed only if the cataract has reached a
sufficient level of severity.
Pathological studies of cataractous lenses have revealed that cataracts are
composed of protein aggregates that precipitate in lens cells of the eye. The insoluble
protein species obstructs the passage of light through the lens, thereby, blocking light
from reaching the photoreceptors in the retina (Benedek 1997).
The human eye lens, as a tissue, is composed of layers of fibrous cells that
continuously grow with age. Crystallins comprise 90% of the total protein content of the
lens (Oyster 1999). The ubiquitous crystallins are expressed primarily early in life and
they, therefore, must remain stable throughout a person's lifetime despite the high protein
concentration in the lens and the continued presence of oxidative stress from atmospheric
oxygen, UV, and visible light to maintain transparency.
In addition to the unique cellular structure of the lens, the overall protein
concentration within these cells is extremely high (approaching 70% g/g wet volume). A
short-range order exists between the tightly packed crystallin proteins in the lens that
provides minimal solution turbidity and a high degree of light transparency (Delaye and
Tardieu 1983).
Cataracts removed from the human eye lens are composed of different species of
aggregated crystallins. The cataractous crystallin proteins may be divided into two
categories: a-crystallins and y-crystallins. a-crystallin is a member of a class of small
heat-shock proteins thought to bind to unfolded polypeptide chains during times of stress
and is thus crucial to preventing protein aggregation (Horwitz 2000; Clark and
Muchowski 2000; MacRae 2000).
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f3y-crystallins are small 20-30 KDa proteins primarily composed of anti-parallel
b-sheets. [3- and y-crystallins are structurally similar. They are both comprised of four
Greek-key motifs separated into two domains (Wistow et al.). The domains are very
similar and appear to be the result of gene duplication during evolution. The P3-crystallins
form domain-swapped dimers in solution due to their flexible linker sequence, whereas
the y-crystallins are monomeric in solution (Jaenicke 1999). In addition, the y-crystallins
are the only known crystallins having attractive forces between molecules (Tardieu et al.
1992; Clark 1994). Extensive biophysical studies have been performed on members of
the y-crystallin family proteins in vitro (Pande et al. 1991; Wenk et al. 2000; Norledge
et al. 1997; Rudolph et al. 1990; Mayr et al. 1997; Slingsby et al. 1997).
Human yD crystallin (HyD-Crys) is a 173 amino acid protein. HyD-Crys has a
high sequence similarity to its bovine homologues, bovine yD crystallin (-86%) and
bovine yB crystallin (-75%) (Slingsby et al. 1997). The human structure modeled using
the bovine y-crystallin 3-D structures is shown in Figure 2-1 (Guex and Peitsch 1997;
Peitsch 1995 and 1996). The structure of the human protein, has been determined from
crystals grown from the human recombinant protein and is fully homologous with the
bovine structure (Christine Slingsby, personal communication). HyD-Crys has four
intrinsic tryptophans that may be used to probe the unfolding/refolding progression of the
molecule with fluorescence spectroscopy.
Human genetic studies of families exhibiting juvenile-onset cataracts identified a
set of surface amino acids of HyD-Crys, including R1 14C, R38H, and R36S (Heon et al.
1999; Kmoch et al. 2000). Site-specific mutagenesis of recombinant HyD-Crys in
collaboration with the laboratory of George Benedek (MIT Physics Department),
confirmed that these substitutions influence the protein's phase transition characteristics
in vitro (Pande et al. 2000 and 2001). The mutation R114C resulted in the presence of an
extra solvent-exposed cysteine that formed a disulfide bond with the endogenous solvent-
exposed cysteine, Cys 110 (Pande et al. 2000). The disulfide linkage caused the
formation of high molecular weight oligomers that precipitated out-of solution in vitro.
The mutations R38H and R36S are associated with aculeiform and congenital juvenile-
onset cataracts, respectively. These juvenile cataracts have distinctive morphologies that
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suggest protein crystallization occurs within the lens. The purified mutant proteins
exhibited decreased solubility in vitro (Pande et al. 2001). This alteration in the phase
separation characteristics was due to an increased crystal nucleation rate of HyD-Crys,
consistent with the pathology of the inherited amino acid substitutions. Based on the
importance of HyD-Crys in juvenile-onset cataracts, the protein is likely to be an
important substrate in the formation of age-onset cataracts as well.
Numerous studies using polypeptides, including many conferring disease
phenotypes, such as ca-synuclein, transthyretin, and the A-42 peptide have demonstrated
that protein aggregation is often an ordered polymerization process that proceeds via a
distinct mechanistic pathway involving a series of specific non-native interactions (Betts,
et al. 1999; Harper et al. 1997; Li et al. 2001; Lashuel et al. 1998, Speed et al. 1995). The
aggregation pathway of the P-sheet P22 tailspike protein is known to proceed from a
destabilized folding intermediate (Haase-Pettingell and King 1988; Speed et al. 1995).
We were interested in the possibility that the mechanism of aggregation of HyD-Crys in
the aging lens differed from juvenile onset genetic cataracts and proceeded from a
partially unfolded conformer of the wild type protein (Mitraki and King 1989; Wetzel
1994).
The unfolding and refolding of bovine yB crystallin has been carefully studied by
Jaenicke and his colleagues (Rudolph et al. 1990; Mayr et al. 1997; Jaenicke 1999). They
described a complex unfolding transition suggesting the presence of a partially folded
intermediate with one of the domains ordered and the other disordered.
To explore the possible relationship of protein folding to cataract formation, we
have performed a series of unfolding/refolding studies on HyD-Crys at or near
physiological pH and temperature (pH 7.0, 37°C). The experiments identify an
aggregation-prone state of HyD-Crys populated in low concentration of guanidine
hydrochloride (GdnHCl). We present direct evidence from atomic force microscopy that
the aggregation pathway of human yD crystallin is ordered and the protein forms fibrils in
vitro.
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AB
Figure 2-1
Hypothetical ribbon structure of human yD crystallin showing the location of the four
tryptophans at positions 43,69,131, and 157. The structure was determined by threading
the HyD-Crys through the known bovine yD crystallin structure (Guex, et al. 1997,
Peitsch, 1995 & 1996). The structure is shown from the side (A) and the top (B).
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B. MATERIALS AND METHODS
i. Expression and purification
Recombinant human yD crystallin was prepared from E. Coli as described (Pande
et al. 2000). Briefly, the protein was purified by fractionating cell lysate on a size
exclusion column followed by cation-exchange chromatography as described (Broide et
al. 1991).
ii. Circular dichroism
CD spectra of native and refolded protein were collected on an Aviv Associates
(Lakewood, NJ) model 202 circular dichroism spectrometer. All readings were
performed on 0.1 mg/mL HyD-Crys protein samples.
iii. Equilibrium refolding and unfolding
For the unfolding equilibrium titration, purified HyD-Crys was diluted to 10
gg/ml in increasing amounts of GdnHCl in S buffer from 0 to 5.5 M. S buffer contained
10 mM NaPO 4, 5 mM DTT, 1 mM EDTA, pH 7.0. The samples were incubated at 37°C
until equilibrium was reached (about 6 hours). For the refolding titration, 100 gg/ml
protein was denatured in 5.5 M GdnHCl in S buffer at 370C for 5 hours. The protein was
subsequently refolded by dilution to 10 gg/ml into decreasing concentrations of GdnHCI
from 5.5 to 0.55 M. The fluorescence spectra of the equilibrated samples were
determined using a Hitachi F-4500 fluorimeter equipped with a continuous temperature
control system with excitation at 295 nm and emission from 310 to 420 nm. The
emission intensities at 350 nm were used for data analysis. The excitation and emission
slits were both set to 10 nm.
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iv. Unfolding fluorescence kinetics
Tryptophan environment changes with refolding were monitored using a Hitachi
F-4500 fluorimeter equipped with a continuous temperature control system. Native
protein (100 pgg/ml in S buffer at 370C) was unfolded by dilution into S buffer to final
concentrations of 10 gg/ml HyD-Crys and 5.5 M GdnHCl. Loss of global structure was
monitored with continuous excitation at 295 nm and emission at 350 nm at 37C.
v. Refolding fluorescence kinetics
Tryptophan environment changes with refolding were monitored using a Hitachi
F-4500 fluorimeter equipped with a continuous temperature control system. Native
protein was denatured at 100 gg/ml concentration in 5.5 M GdnHCl in S buffer at 37°C
for 5 hours. The unfolded protein was refolded by dilution into S buffer to final
concentrations of 10 gg/ml HyD-Crys and 0.55 M GdnHC1 or 1.5 M GdnHCl. Increase
in global structure while refolding was monitored with continuous excitation at 295 nm
and emission at 350 nm. Fluorescence wavelength spectra were obtained after 5 hours of
refolding both before and after a 20-minute spin at 12,000 rpm. A background
fluorescence correction was made by obtaining spectra of S buffer containing 0.55 M
GdnHCl and subtracting it from the refolded sample data.
vi. Refolding solution turbidity kinetics
Solution turbidity changes caused by formation of high molecular weight species
were monitored with refolding in a Cary 50 Bio UV/Vis spectrophotometer. Samples
were prepared as discussed for the refolding fluorescence kinetic experiments.
Absorbance spectra from 260 to 350 nm were monitored at various time intervals.
Absorbance values at 280 nm were used for data analysis. Samples were stirred
throughout the refolding process.
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vii. Atomicforce microscopy
AFM analysis was performed using the tapping method as described (Marini et al.
2002). Ten gl of sample was allowed to nonspecifically bind to a mica surface for a total
drying time of 75 seconds. The mica was then washed with 150 gl of milli-Q water and
allowed to air-dry before imaging.
viii. BisANS binding assay
The character of the HyD-Crys aggregate was probed by monitoring bisANS
fluorescence changes upon binding. HyD-Crys aggregates were prepared by refolding
denatured protein in 0.55 M GdnHCl in S buffer at 10 jgg/ml HyD-Crys at 370 C. Samples
were removed at refolding time intervals ranging from 30 seconds to 4 hour. BisANS
was added to the resulting sample to reach a final small molecule concentration of 20 nM.
The fluorescence spectrum of the sample was determined by excitation at 350 nm and
emission from 400 to 600 nm on a Hitachi 4500 fluorimeter. Background fluorescence of
bisANS in 0.55 M GdnHCl was subtracted from the resulting spectrum for data analysis
purposes.
C. RESULTS
i. Purification
Recombinant human yD crystallin was expressed from a pET. 16 plasmid in E.
Coli strain BL21(DE3). The recombinant HyD-Crys expressed in E. coli folded into
soluble protein subunits that were stable in the bacterial cytoplasm. Methods developed
for the purification of yD crystallin from the bovine lens were used to purify the crystallin
subunits from the bacterial lysate (Pande et al. 2000). Recombinant HyD-Crys contained
an N-terminal methionine that is post-translationally cleaved in the native protein. The
crystallin purified from E. Coli had far-UV CD (Figure 2-2) and absorption spectra (data
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not shown) similar to those observed for soluble bovine yD crystallin extracted from calf
lenses (Hay et al. 1994). X-ray diffraction studies of crystals grown from the
recombinant protein indicated the same fold as that found for the bovine protein (Basak et
al. 2003).
ii. Equilibrium unfolding and refolding
Human yD crystallin did not denature in urea at concentrations in excess of 8 M,
but did exhibit a denaturation transition in GdnHCl. Unfolding and refolding transitions
were examined using GdnHCl as the denaturant in equilibrium analyses. Buffers were
maintained at pH 7 and temperatures of 25°C or 37°C. Under these conditions a
cooperative unfolding transition occurred in the range of 2.0 to 3.3 M GdnHC1.
With respect to the overall tryptophan fluorescence, the native-state of the protein
was quenched to a greater extent than the denatured state (Figure 2-3A). Based on the
hypothesized structure of HyD-Crys, that native-state fluorescence quenching may occur
because each of the four tryptophan side-chains present in the protein are within close
proximity to polar residues. The maximum fluorescence intensity of native HyD-Crys
occurred at 325 nm while the maximum fluorescence intensity of denatured protein
occurred at 348 nm.
At 37°C, the unfolding equilibrium transition of HyD-Crys at 350 nm showed that
protein unfolding was a two-state process (Figure 2-3B). Control titrations with sodium
chloride demonstrated that fluorescence changes observed in high and low denaturant
concentrations reflected structural alterations in the protein as opposed to high salt effects
from GdnHCl (data not shown). UV/Vis solution turbidity experiments did not reveal the
presence of any high molecular weight aggregates.
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Figure 2-2
Far-UV CD spectrum of 0.1 mg/mL recombinant HyD-Crys in S Buffer purified from E.
Coli lysates.
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Figure 2-3
Equilibrium unfolding and refolding of HyD-Crys in GdnHCl. Intrinsic tryptophan
fluorescence was monitored of HyD-Crys during folding and refolding and all samples
were equilibrated in S buffer at a protein concentration of 10 llg/ml. (A) Fluorescence
wavelength spectra of native protein (0), denatured protein in 5.5 M GdnHCI (_), HyD-
Crys refolded at 0.55 M GdnHCI before a 12,000 rev/min centrifugation (.), and after a
20 minute centrifugation (x) at 37°C. (B) Relative fluorescence intensity of unfolding
(.) and refolding (0) at 350 nm at 37°C. (C) Fraction unfolded intensity of unfolding
(.) and refolding (0) at 350 nm at 25°C. Fraction unfolded values were calculated from
raw fluorescence intensity measurements using the method described by Pace et al.
(1989). Samples were allowed to equilibrate for 6 hours in the appropriate conditions.
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At 37°C, the refolding transition of HyD-Crys appeared to be reversible in
GdnHC1 concentrations above 1.0 M GdnHCl, though with the suggestion of a hysteresis
in the transition region (Figure 2-3B). Dilution of denatured protein to GdnHCl
concentrations lower than 1.0 M gave rise to a protein species with non-native tryptophan
environments as demonstrated by increased fluorescence intensity and wavelength
maximum shifts to 330 nm (Figure 2-3A). These samples contained high molecular
weight protein aggregates as evidenced by solution turbidity measurements.
Equilibrium refolding and unfolding of HyD-Crys as a function of GdnHCl
concentration at 25C was similar to 370 C, but the refolding and unfolding transition
curves did not overlay and exhibited hysteresis. The midpoint of the unfolding transition
at 25°C was 3.7 M GdnHCl while the midpoint of the refolding transition was 2.7 M. At
37°C the midpoints of both the unfolding and refolding transitions were approximately
2.7 M GdnHCl. The refolding aggregation reaction at low GdnHCl concentration
observed at 37C was also visible at 250 C.
To further examine the nature of the aggregation reaction, we characterized the
aggregation reaction as a function of sample incubation time after initiation of refolding
at 37°C. Native protein exhibited no appreciable increase in solution turbidity after 40
hours of incubation under these conditions. The location of the aggregation transition
was not altered with increasing times of incubation after dilution from 3 to 40 hours.
This suggested that the reaction depended on the population of a distinct conformer
during refolding in 1 M GdnHCl and did not require a rate-limiting nucleation event
(Figure 2-4). Samples containing a final GdnHCl concentration greater than 1.0 M did
not exhibit appreciable solution turbidity even after 40 hours. We did not observe
aggregation in the major conformational transition occurring from 2 to 3.3 M GdnHCl
indicating that intermediates populated in this transition were not the precursors of the
aggregated state.
The HyD-Crys protein refolded in aggregation-prone conditions (0.55 M
GdnHCl) was centrifuged at 12,000 rev/min. Solution turbidity measurements measured
at 280 nm and 350 nm indicated no high molecular weight aggregates remained in the
supernatant after centrifugation (data not shown). The fluorescence spectrum of the
resulting supernatant revealed that a significant portion of the protein was lost to
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precipitation, but the fraction remaining had a maximum intensity wavelength
indistinguishable from native (Figure 2-3A). This indicated that there was a native-like
species present at the end of the reaction and that the off-pathway aggregation process
competed with a productive refolding pathway under aggregation-prone conditions.
Integration of the fluorescence wavelength spectra of the resulting supernatant in the
experiment shown in figure 2-3 revealed that 50% +/- 2% of the protein was refolded
productively and 50% +/- 2% of the protein became incorporated into the aggregate.
iii. Kinetic unfolding through a partially unfolded intermediate
The unfolding of HyD-Crys was monitored over time with fluorescence at 37°C
(Figure 2-5, Table 2-1). A possible early intermediate (Iul) may have been populated
within the dead-time of the experiment as indicated by the burst fluorescence intensity at
the on-set of the experiment. The only observable intermediate (Iu2) formed with a t/ 2 of
55 s. This intermediate was not as quenched as native indicating the polar-tryptophan
interaction had been disrupted. In the final unfolding transition (Iu2 -- denatured),
occurring with a t1/2 of 2700 s, a slow re-quenching took place indicative of solvent
rearrangement or isolated local restructuring in the unfolded state. The unfolding process
was completed in -2 hours.
kul? ku 2 ku 3
N -r Iul? -- Iu2 Denatured (2.1)
Solution turbidity measurements showed no evidence of aggregation during this process.
HyD-Crys showed the same kinetic rates and intermediates during unfolding regardless of
pH, temperature, starting concentration of protein, and presence or absence of DTT (data
not shown).
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Figure 2-4
Behavior of refolding HyD-Crys species as a function of incubation of the reactions. The
intrinsic tryptophan fluorescence of the aggregation-prone region of the refolding
equilibrium was monitored with excitation at 295 nm and emission at 350 nm at 37°C in
S buffer for 3 hours (0), 6 hours (~), 17 hours (+), and 41 hours (D).
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Figure 2-5
Unfolding kinetics of HyD-Crys monitoring intrinsic tryptophan fluorescence with
excitation at 295 nm and emission at 350 nm. HyD-Crys was denatured by rapid dilution
into 5.5 M GdnHCl at 37°C in S buffer to a final protein concentration of 10 Jlg/ml. The
unfolding protein time course is shown in gray with the resulting three-state curve fit
(dashed line).
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Table 2-1
Kinetic rate constants for unfolding, productive refolding and aggregation of Human yD
Crystallin
kI__1/2 k2 t1/2l2 k3 tl/2
Unfolding <0.46 <15 s 0.013 55 s 0.00027 2700 s
Refolding/Aggregation <0.46 <15 s 0.012 60 s 0.00028 2500 s
Productive Refolding <0.46 <15 s 0.0095 73 s 0.00067 1030 s
iv. Competing productive and aggregation-prone refolding pathways
Solution turbidity was monitored at varying time intervals during refolding of
HyD-Crys under aggregation prone conditions (Figure 2-6, Table 2-1). The solution
turbidity of the first observable species was significantly higher than the native control
indicating that a high molecular weight species (I1 *) had already formed within the dead-
time of the experiment. The formation of the first visible high molecular weight species
(I2*) occurred with an approximate tli2= 60 s while the second state change (12* to
aggregate) had an approximate t/2 =3000 s. This second transition may have reflected a
slow structural transition of the multimeric protein from a highly turbid species to a less
turbid species, but also may have corresponded to the progressive precipitation of the
aggregate from solution.
kl *? k2* k3*
D -> I *? - 12* - Aggregate (2.2)
This aggregation mechanism was independent of the presence of reducing agents such as
DTT and intermediates were confirmed by fluorescence scans (data not shown).
In order to study the kinetic rates and intermediates formed during productive
refolding of HyD-Crys without the impact of light scattering, fluorescence experiments
were performed on HyD-Crys refolding to a final denaturant concentration of 1.5 M
GdnHCl (Figure 2-7, Table 2-1). Under these conditions, fluorescence equilibrium data
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revealed the refolding process favored a native-like conformation and no high molecular
weight species were detected in solution turbidity measurements. Productive refolding
had a possible early intermediate (Ii) that may have formed within the dead-time of the
experiment as evidenced by the burst in fluorescence observed at 15 seconds.
Spectroscopically, the only visible intermediate (12) formed with a t/2 of 73 s and then
was converted to native protein with a t1/2 of 1030 s. Under these conditions,
productively refolded HyD-Crys reached equilibrium in approximately 3 hours whereas
refolding HyD-Crys under aggregation-prone conditions did not reach equilibrium until 4
hours had passed.
kl ? k2 k3
D - I ? - 12 -> Native-like (2.3)
The final state of the protein under these non-aggregating refolding conditions was
native-like in terms of its fluorescence character.
v. The self-associated aggregate has a fibril structure
Atomic force microscopy was used to probe the structure and aggregation
mechanism of HyD-Crys. Native crystallin from an S buffer solution was visible upon
non-selective binding to the mica surface. The molecules had an apparent height of 0.5
nm, a length of 10 nm, and a width of 10 nm (Figure 2-8A). The discrepancy between
this value and the predicted dimensions of the protein (50 A by 30 A by 30 A) were
presumably a result of either molecular flattening upon binding, resolution limits of the
technique, or dimerization of the protein under the sample preparation conditions. The
molecules appeared to contain a region of low height in the very center.
A solution of HyD-Crys was denatured in 5.5 M GdnHCl and subsequently
refolded using the aggregation-prone conditions (dilution to 0.55 M GdnHCI). Ten gL
samples were removed and applied to a mica grid at various intervals.
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Figure 2-6
Solution turbidity measurements of refolding HyD-Crys over time. HyD-Crys was
denatured in 5.5 M GdnHCI at 37°C in S buffer for 5 hours. HyD-Crys was refolded by
rapid dilution with S buffer to a final GdnHCI concentration of 0.55 M and a final protein
concentration of 10 f.lg/ml. Relative solution turbidity was determined by measuring
refolding HyD-Crys absorbance at 280 nm at various times (.). A background buffer
scattering reference is shown for comparison (0).
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Figure 2-7
Refolding kinetics of HyD-Crys monitoring intrinsic tryptophan fluorescence with
excitation at 295 nm and emission at 350 nm. HyD-Crys was denatured in 5.5 M
GdnHCI at 37°C in S buffer for 5 hours. HyD-Crys was refolded by rapid dilution with S
buffer to a final GdnHCI concentration of 0.55 M (A) and 1.5 M (B)(and a final protein
concentration of 10 J.lglml. The refolding protein time course is shown in gray with the
resulting three-state curve fit. Reference native (solid line) and denatured (dotted line)
intensities are shown for comparison.
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Figure 2-8
AFM height images of refolding HyD-Crys species absorbed to a mica surface. High
surfaces are denoted as white (5 nm) and low surfaces are shown in black (0 nm). HyD-
Crys was refolded for various times, extracted from solution, absorbed on mica, and
observed using tapping mode AFM. Native HyD-Crys (A), and protein refolded for 1
min. (B), 5 min. (C), 24 min. (D), 1 hr. (E), and 2 hr. (F) are shown. Panel A is a 300 om
x 300 om scanning area while B-F are 1 J..lmx 1 J..lm.The inset in B is a close-up of
refolded HyD-Crys.
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Within the first minute of refolding, small globular structures were visible (Figure
2-8B). In the background of this image, native-like HyD-Crys monomers are already
visible, supporting the competing aggregation and productive pathway model for
refolding under these conditions. After approximately 5 minutes of refolding, long, thin,
1 nm high, 15 nm wide, protofibril structures were observed (Figure 2-8C). The
protofibrils had an approximate width and height of the soluble crystallin. After about 24
minutes of refolding, protofibrils were visible but were found only in associated masses
(Figure 2-8D). The protofibrils had begun to associate from the center producing a
species with one thick mid-region and multiple fibril-width tail ends. By one hour of
refolding, virtually all of the protofibrils had disappeared, presumably being incorporated
into thick 5 nm high, 50 nm wide branched and unbranched fiber bundles (Figure 2-8E).
Although the exact height and width of the fiber bundles varied, their overall appearance
and approximate size was similar. After several hours of refolding, aggregated masses
were visible presumably containing associated fiber bundles (Figure 2-8F).
vi. The aggregate contains exposed hydrophobic pockets
HyD-Crys aggregates were characterized by binding assays with bisANS. All
aggregated species, including nuclei presumably present as early as 30 seconds after the
start of refolding and fiber bundles present at 4 hours, bound bisANS significantly better
than either the unfolded or folded control (Figure 2-9A and 2-9B). This indicated that all
HyD-Crys aggregates under these conditions had non-native patches of exposed
hydrophobic residues.
D. DISCUSSION
i. Crystallin refolding and aggregation in vitro
Within the eye, the lens crystallins exhibit very long lifetimes at very high
concentrations in the presence of ultraviolet and visible radiation. Recombinant human
83
yD crystallin was resistant to denaturation by concentrations of urea up to 8 M at neutral
pH, but could be denatured upon incubation with high concentrations of GdnHCl. The
midpoint of the transition occurred at about 2.7 M GdnHCl, at 37°C.
Within folded HyD-Crys the fluorescence intensity is representative of quenched
tryptophans. Wistow et al. suggested that fluorescence quenching of the native state
observed in bovine y-crystallin proteins is caused by tryptophan-cysteine interactions.
The native-state quenching of HyD-Crys may be due to the interaction of cysteine thiols
19 and 79 with tryptophan 43, cysteine 33 with tryptophans 69, and/or histidine 88 with
tryptophan 131. This phenomenon has been observed in other proteins such as cellular
retinoic acid binding protein and human serum transferring N-lobe (Eyles and Gierasch
1999; He et al. 2001). The packing of cysteines against tryptophans may provide a
mechanism of protection in the eye from free radical damage initiated by ultraviolet
radiation absorption by tryptophans (Davies and Truscott 2001). However, the source of
the quenching has not been experimentally determined and may be associated with other
residues in the hydrophobic core.
The denatured chains of HyD-Crys could be refolded by dilution from GdnHCl
and the reaction was reversible with one distinct transition in the range of 1-5 M GdnHC1.
Bovine yB crystallin, which is denatured by urea at pH 2.0, but not at pH 7.0, was
reversible over all reported concentrations of GdnHCl, but exhibited a three-stage
transition in equilibrium unfolding studies, representing sequential denaturation of the C-
terminal and N-terminal domains at pH 2.0 (Rudolph et al. 1990; Jaenicke 1999). On the
other hand, the closely homologous protein S, a protein also containing two Greek key
domains, unfolded and refolded without evidence of separate domain transitions (Wenk
et al. 1998). HyD-Crys may possess differential domain stability that is not visible in the
apparent two-state unfolding transition observed during equilibrium unfolding. Future
experiments will attempt to characterize the stability of each domain of the human
protein.
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Figure 2-9
Binding of bisANS to refolding HyD-Crys using bisANS fluorescence with excitation at
360 nm. HyD-Crys was denatured in 5.5 M GdnHCl at 37°C in S buffer for 5 hours.
HyD-Crys was refolded by rapid dilution with S buffer to a final GdnHCl concentration
of 0.55 M and a final protein concentration of 10 gg/ml. Samples of refolded protein
were analyzed at various times, bisANS was added, and small molecule fluorescence was
determined at 500 nm (A). Refolded sample (), denature sample (dashed line) and
reference native (solid line) bis-ANS fluorescence are shown. A representative
fluorescence scan (B) is shown of aggregated (), native (0), and denatured HyD-Crys
crystallin ().
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The in vitro unfolding and refolding steps of human yD crystallin were relatively
slow compared to some small proteins such as RNase or barstar (Hollien and Marqusee
2002; Nolting et al. 1995), but similar to rates found for some other [5-sheet proteins like
apo-pseudoazurin (Reader et al. 2001).
During refolding, dilution into concentrations of GdnHCl below 1.0 M at 370 C,
resulted in the population of an intermediate that aggregated irreversibly. The
aggregating species was populated at low GdnHCl concentrations both at 370 C and at
25°C. At both temperatures, the major conformational transition measured by
fluorescence spectroscopy was in the range of 2 to 3.3 M GdnHCl. This was well
separated from the GdnHCl concentration in which the aggregation reaction was
detected. This suggests that the aggregation-prone intermediate differs from the species
populated in the transition or that perhaps similar intermediates are present under both
conditions but have increased solubility in higher GdnHCl concentrations.
This behavior differs somewhat from other proteins in which aggregation
competes with productive refolding, such as phosphoglycerate kinase, f3-galactosidase,
interleukin 1-3, and transthyretin (Ghelis and Yon 1982; Wetzel and Chrunyk 1994;
Colon and Kelly 1992). For these proteins, dilution to intermediate concentrations of
denaturant generated an aggregating intermediate, while dilution to lower concentrations
led to the recovery of the native fold. Equilibrium analysis with GdnHCl demonstrated
that in HyD-Crys, the aggregating species probably was not generated from a transition
intermediate.
Though not well defined at 37°C, a hysteresis between the unfolding and
refolding equilibrium curves was very clear at 25C. The refolding curves had the same
midpoint of transition at both temperatures; however, the transition midpoint of unfolding
at 37°C occurred at lower GdnHCl concentrations suggesting a thermal destabilization of
the native state.
The existence of hysteresis in protein refolding experiments is associated with
reactions that are kinetically controlled, and which exhibit high energy barriers between
conformational transitions needed for refolding. The folding of a number of P-sheet
proteins are kinetically controlled, for example the parallel 3-helical tailspike adhesin
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(Sturtevant et al., 1989; Chen and King, 1994; Steinbacher et al., 1994). Alkaline
phosphatase exhibits a continuous reorganization of the environment around tryptophan
109 to the native state that takes days under refolding conditions (Subraniam et al., 1995).
The transformation from the io- to the 13-isoform that occurs during refolding of the
recombinant mouse prion protein exhibits a high barrier between the native and the
denatured state as well (Baskakov et al., 2001). For HyD-Crys, the hysteresis was
reduced at higher temperature, consistent with overcoming a kinetic barrier. Correct
packing of the hydrophobic cores or formation of proper domain interface alignment are
candidates for the slow step. The molecular basis of the hysteresis requires further
investigation (Sinclair, et al. 1994; Lai et al. 1997).
ii. Formation offilamentous aggregates
AFM images reveal that the in vitro aggregate of HyD-Crys was ordered. The
aggregate had a filamentous appearance as would be expected from the polymerization of
defined subunits. At early times during aggregation, globular species presumably
representing soluble crystallin species were present. These were approximately 2-5 times
the size of the native crystallin, estimated from the AFM images. These species are
candidates for aggregation nuclei. The exposed surfaces at the growing tip may serve as
intermolecular interfaces. The multimeric nuclei appeared to polymerize into elongated
protofibrils. The thin protofibrils appeared to wind around each other forming fiber
bundles. All protofibrils were incorporated into fiber bundles by 4 hours of refolding.
Additional exposed hydrophobic surfaces may be the site of association or intermolecular
contacts may be made by an unknown mechanism.
The aggregation pathway competed with a productive refolding pathway under
the described conditions, suggesting that a partially folded intermediate might be the
polymerizing species. Neither equilibrium nor kinetic analyses of HyD-Crys unfolding
revealed any evidence for aggregation from the native state of the protein. The native-
like species forming during aggregation-prone refolding had a fluorescence spectra and
AFM structure similar to native HyD-Crys. Due to the low concentration of protein
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present during refolding experiments no other structural evidence was obtainable to
confirm this.
Figure 2-10 shows a model for HyD-Crys refolding and aggregation in vitro. The
initial step on the productive refolding pathway is envisaged to be a global hydrophobic
collapse (reviewed in Ptitsyn 1995; Kuwajima 1992) during which large bulky,
hydrophobic residues are sequestered away from the polar solvent as evidenced by an
increase in the overall fluorescence of the protein. A kinetic partitioning of HyD-Crys
chains occurs between the productive refolding pathway and the aggregated complexes.
The early collapsed intermediate may be the same for the two pathways. In both
aggregation-prone refolding experiments and control productive refolding experiments, a
burst phase was visible at 15 seconds that may correspond to the formation of a similar
early folding intermediate that is prone to polymerization.
The aggregation/productive refolding breakpoint in the refolding pathway must
occur relatively early with respect to the other transition times observed with HyD-Crys
as evidenced by the presence of a species that has a high solution turbidity within the
dead-time (15 seconds) of the spectroscopic kinetic experiments.
The presence of 1.5 M GdnHCl appeared to shift the equilibrium of the branch
point between productive and aggregation-prone folding to favor the productive process
as evidenced by equilibrium analysis as well as kinetic experiments in which HyD-Crys
was refolded by dilution into 1.5 M GdnHCl.
The HyD-Crys aggregate bound bisANS significantly even as early as the
formation of nuclei species, further emphasizing that these aberrant exposed hydrophobic
residues exist from the on-set of refolding. The hydrophobic bisANS binding surfaces
may correspond to the intermolecular interaction domains that facilitate protofibril and
fiber bundle formation. Further work is needed to elucidate which area of the molecule is
responsible for these aggregation-facilitating interactions and which area, if any, retains a
native-like fold.
The aggregation and refolding pathways were dependent on the concentration of
HyD-Crys whereas the unfolding pathway was concentration independent. When the
overall concentration of protein was increased by a factor of ten, the presence of 1.5 M
GdnHCl was not sufficient to quench the aggregation pathway. This high concentration
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aggregation reaction may or may not be the same as the aggregation phenomenon
previously described, but these results do suggest a significant divergence of the in vivo
and in vitro pathways. The amount of crystallin found in the eye lens is 70% (g/g wet
weight) or approximately 300-500 mg/mL whereas the amount of crystallin used for
these experiments was as low as 10 gg/ml (Jaenicke 1999).
iii. Cataractformation in the lens
Many human diseases such as glaucoma and Meretoja's syndrome result in the
expression of insoluble protein fibers in the eye (Nelson et al. 1999; Kivela et al. 1994).
Experiments performed with c-crystallin have demonstrated that a fibrous aggregate
forms when this protein is complexed with [L crystallin (Weinreb et al. 2000), and
amyloid-like protein species have been identified in situ in the mammalian ocular lens
using Congo red and thioflavin T binding assays (Fredrikse 2000). The results reported
here, suggest that old age cataracts should be re-examined for the presence of fibrillar
aggregates containing human yD crystallin.
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Figure 2-10
Model of HyD-Crys folding and aggregation. Upon rapid dilution into refolding
buffer, HyD-Crys undergoes a global hydrophobic collapse. A fraction of the refolding
molecules proceed to refold rapidly into a native state through a series of
spectroscopically observable intermediates. The remaining fraction of the refolding
chains will undergo a specific non-native interaction sequence ultimately resulting in the
formation of an elongated aggregate. Spectroscopic techniques reveal three observable
aggregation pathway states (1*, and 12*) and AFM images show three distinct
aggregation intermediates (nuclei, protofibrils, and fiber bundles). We hypothesize that
multiple-fiber bundles can associate, ultimately forming an aggregate mass.
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CHAPTER III: ASSIGNMENT OF TRYPTOPHAN FLUORESCENCE OF
HUMAN yD CRYSTALLIN USING TRIPLE TRYPTOPHAN TO
PHENYLALANINE MUTANT PROTEINS
A. INTRODUCTION
Human mature onset cataracts affect nearly 15% of the US population over 40
years of age and are the leading cause of blindness worldwide (NEI 2002). Pathological
studies of cataractous lenses have revealed that cataracts are composed of protein
aggregates that precipitate or polymerize in lens cells of the eye (Oyster 1999).
Human yD crystallin (HyD-Crys) is a protein synthesized during embryonic
development that must remain soluble in the anucleated cells of the adult human eye lens
for proper vision. Covalently modified HyD-Crys has been recovered in protein
aggregates removed from aged, cloudy lenses (Hanson et al. 2000). HyD-Crys has 173
amino acids and shows high sequence and structural similarity to other y-crystallins
(Basak et al. 2003). Mutations in the gene encoding HyD-Crys have been found in
families exhibiting juvenile onset cataracts further implicating HyD-Crys in
cataractogenesis (Nadrut et al. 2003; Heon et al. 1999; Pande et al. 2001).
HyD-Crys is composed of anti-parallel P-sheets arranged in four Greek-key
motifs separated into two domains (Figure 3-1). The two domains show high levels of
structural and sequence conservation and appear to be the result of gene duplication
during evolution (Wistow et al. 1983). Like most soluble y-crystallins, HyD-Crys is
monomeric in solution (Jaenicke 1999). HyD-Crys has four tryptophans that have been
used to probe unfolding and refolding progression with fluorescence spectroscopy
(Kosinski-Collins and King 2003).
The fluorescence signal of HyD-Crys increases when the protein is denatured in
high concentrations of guanidine hydrochloride (GdnHCl). This indicates that the
tryptophan fluorescence is quenched in the native state.
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Although this phenomenon has been observed in other proteins without metal
ligands or cofactors (Lakowicz 1999; Eyles and Gierasch 1999; He et al. 2001), it is
uncommon. Ultraviolet light has been proposed as one of the etiological agents of
cataract formation (McCarty and Taylor 2002; Sasaki et al. 2002). The presence of
tryptophan in the lens proteins may function in protecting the retina from ultraviolet light
damage (Kurzel et al. 1973). In this case, fluorescence quenching may protect the lens
proteins from ultraviolet light absorption. We have investigated which residues are
involved in the quenching reaction to provide possible insight into the ability of the lens
proteins to maintain stability and transparency over the human lifetime.
We constructed triple mutant tryptophan constructs each containing only one of
the four native tryptophans of HyD-Crys to determine the origin of the anomalous
quenching signal.
B. MATERIALS AND METHODS
i. Cloning and site-directed mutagenesis
The human yD crystallin coding sequence had been previously cloned as
described (Pande et al. 2000). The gene was excised from the pET3a plasmid and ligated
into a pQE. 1 plasmid (Qiagen) that added an N-terminal 6-His tag to the protein. The
integrity of the HyD-Crys gene was confirmed by sequencing at the facilities of
Massachusetts General Hospital.
Four triple mutant proteins containing three tryptophan to phenylalanine
substitutions at positions 42, 68, 130, and 156 were constructed using a PCR-based
mutagenesis procedure (Stratagene). Sequential mutations were made using
complementary primer pairs that altered the Trp codon TGG to Phe TTT (Invitrogen).
The mutations were confirmed by sequencing the region of the resulting plasmids
(MGH).
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Figure 3-1
Ribbon structure of wild-type human yD crystallin showing the location of the four native
tryptophans at positions 42, 68, 130, and 156 (Basak et al. 2003).
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ii. Expression and purification of triple mutants
Recombinant HyD-Crys was prepared by pQE. 1 plasmid transformation into E.
Coli M15 (pREP4) cells. Protein production was induced by addition 1 mM IPTG and
allowing 4 hours of incubation at 37C. Cultures were pelleted by centrifugation for 15
min and cells were resuspended in a 10 mM imidazole, 10 mM Tris, 0.5 M NaCl
solution. Cells were lysed using six sequential 20 second bursts of sonication followed
by 40 second rest cycles. Lysates were spun at 17,000 RPM for 30 minutes. The
resulting supernatant was then applied to a Ni-NTA column and protein was eluted using
an increasing concentration of 250 mM imidazole, 10 mM Tris, 0.5 NaCl at room
temperature. Fractions containing protein were dialyzed four times against four liters of
10 mM ammonium acetate pH 7.0 for four hours. Maldi mass spectroscopy was
performed on all proteins to confirm the presence of the desired amino acid substitutions
(MIT-Biopolymers Lab). All proteins were transferred from ammonium acetate to S
Buffer (10 mM NaPO4, 5 mM DTT, 1 mM EDTA, pH 7.0) by dilution.
iii. Circular dichroism
CD spectra of wild type and mutant HyD-Crys proteins were collected on an Aviv
Associates (Lakewood, NJ) model 202 circular dichroism spectrometer. All readings
were performed on 0.3 mg/mL HyD-Crys protein samples in S buffer at 37°C. CD was
measured every 1 nm between 200 and 260 nm. The signals at all wavelengths were
averaged over 5 seconds.
iv. Ultraviolet light absorbance
Ultraviolet light spectra of wild-type and mutant HyD-Crys proteins were
collected on a Varian Cary 50 Bio ultraviolet light spectrometer. Readings in the peptide
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backbone region (190 nm to 240 nm) were performed on 0.1 mg/mL HyD-Crys in S
buffer. Absorbance readings in the aromatic region (240 nm to 340 nm) were taken of
0.3 mg/mL protein samples in S buffer (native) or S buffer containing 5.5 M GdnHCl
(denatured). Protein concentration was calculated by measuring denatured protein
absorbance at 280 nm and using a protein extinction coefficient of 41.04 mM-' for wild-
type and 23.97 mM-1 for triple mutant tryptophan His-tagged constructs, respectively.
v. Fluorescence emission spectra
Fluorescence emission spectra were read on a Hitachi F-4500 fluorimeter with a
continuous flow temperature control system. Proteins were diluted to a concentration of
10 gg/mL in S buffer or S buffer containing 5.5 M GdnHCl. Samples were excited at
295 nm and emission was measured from 310 nm to 420 nm. The excitation and
emission slit widths were both set to 10 nm. The background fluorescence of S buffer or
S buffer and 5.5 M GdnHCl was subtracted from the sample reading. Fluorescence
emission maxima were calculated by averaging signals over every 5 nm and selecting the
midpoint of the five signals that exhibited the highest average.
C. RESULTS
i. Purification of his-tagged crystallin
The cloned HyD-Crys gene (Pande et al. 2000) was excised from a pET3a
plasmid and ligated into a pQE. 1 plasmid as described in Material and Methods. This
plasmid added an N-terminal MKHHHHHHQ peptide to HyD-Crys. The addition of this
peptide did not affect expression of HyD-Crys or the ability of the protein to fold into a
native-like state during purification. In addition, we were not able to detect differences in
the fluorescence or circular dichroism spectra (CD) of the His-tagged protein. The
thermodynamic and kinetic unfolding and refolding properties of the His-tagged species
were identical to the wild-type protein (results not shown).
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Four triple mutant proteins were constructed using site-directed mutagenesis.
Each contained three tryptophan to phenylalanine substitutions retaining one native
tryptophan (W42-only, W68-only, W130-only, and W156-only). All mutant plasmids
were transformed into E. Coli M15(pREP4) cells and the proteins expressed during
incubation at 37C. Wild type and all four triple mutant proteins of HyD-Crys
accumulated primarily in the soluble fraction of the cell lysates (>60%). These proteins
were purified using the protocol developed for wild-type His-tagged HyD-Crys. The four
mutant proteins behaved similarly to wild type during the purification procedure.
ii. Structure assignment
CD, native gel electrophoresis, and ultraviolet light absorbance were performed to
assess the overall conformations of the mutant proteins.
Native gel electrophoresis of wild type and the triple mutant tryptophan constructs
confirmed that all proteins retained similar native conformations. His-tagged wild-type
HyD-Crys shows three distinct bands when separated on a native polyacrylamide gel due
to different charge states and/or degradation products. All mutant constructs exhibited
similar native bands running with analogous mobility as wild type (results not shown).
Far-UV CD of the native proteins showed a primarily 5-sheet structure for wild-
type HyD-Crys and all four triple mutant tryptophan constructs at 37C, pH 7.0 (Figure 3-
2). All five proteins had a characteristic [3-sheet minimum at 218 nm although the
amount of -structure appeared to vary between the different constructs. In addition,
none of the mutant proteins exhibited the inflection shown by wild-type HyD-Crys at 208
nm (Kosinski-Collins and King 2003) indicating that some of the secondary structure of
wild type was diminished in the mutant proteins. The tryptophan to phenylalanine
mutations may have slightly disrupted local 1-sheet structures, leading to the altered CD
signal at 218 nm, while maintaining overall conformations similar to wild type as
observed by native gels.
The W68-only construct displayed the characteristic inflection of wild type
observed in far-UV CD at 235 nm. W156-only showed a slight arc around this
wavelength that was not as pronounced as W68-only. This may have been due to the
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overall decreased signal of W156-only. Therefore, it seems that the inflection in the
wild-type spectrum at 235 nm reports environments around Trp 156 and Trp68.
Ultraviolet light absorbance scans in the peptide backbone region of native wild-
type, W42-only, W68-only, W130-only, and W156-only HyD-Crys showed similar
spectra between 190 nm and 240 nm at 37C, pH 7.0 (results not shown). Ultraviolet
light spectra in the region of tyrosine and tryptophan absorption were also obtained from
native and denatured proteins at 37°C, pH 7.0. All proteins had absorbance spectra
typical of polypeptides containing high numbers of tryptophan and tyrosine residues with
a maximum at 276 nm. Absorption spectra of denatured states of the triple mutant
tryptophan mutants overlaid uniformly indicating that all tryptophans were in similar
denatured environments (Figure 3-3A). Ultraviolet light absorbance spectra of native
triple mutant tryptophan proteins exhibited the same overall shape and character, but had
slightly different overall absorbance intensities (Figure 3-3B). This indicated that Trp42,
Trp68, Trp 30, and Trp156 were found in slightly different tertiary environments.
iii. Fluorescence spectra
The overall character of the fluorescence emission spectra of wild-type, W42-
only, W68-only, W130-only, and W156-only HyD-Crys were assessed by exciting the
protein at 295 nm and observing fluorescence emission intensities from 310 to 420 nm in
either S buffer or S buffer and 5.5 M GdnHCl (Figure 3-4 and Table 3-1). S buffer
contained 10 mM NaPO 4, 5 mM DTT and 1 mM EDTA and was prepared at pH 7.0.
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Figure 3-2
Far-UV CD of wild-type His-tagged HyD-Crys (), W42-only (), W68-only (),
W130-only (), and W156-only (0). Samples were prepared at a 300 g/mL protein
concentration and equilibrated in S buffer at 37C.
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Figure 3-3
Aromatic residue ultra violet light absorbance spectra of His-tagged HyD-Crys at 100
ptg/mL protein in S buffer at 370C. Wild type (*) and a representative triple mutant
tryptophan protein, W42-only (U) are shown denatured in 5.5 M GdnHCl (A). W68-
only, W130-only, and W156-only exhibit denatured spectra indistinguishable from W42-
only. Native protein aromatic absorbance is shown of wild-type His-tagged HyD-Crys
(*), W42-only (1), W68-only (O), W130-only (0), and W156-only (0) (B). Thirty
percent of the data points are shown.
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Figure 3-4
Fluorescence emission of native () and denatured (O) HyD-Crys. Protein was excited
at 295 nm and emission spectra were collected from samples of 10 gg/mL protein in S
buffer or S buffer and 5.5 M GdnHCl at 370 C. Fluorescence spectra of wild-type His-
tagged HyD-Crys (A), W42-only (B), W68-only (C), W130-only (D), and W156-only (E)
are shown.
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Wild-type His-tagged HyD-Crys had a native fluorescence emission maximum of
326 nm, and was quenched in the native state. The denatured protein exhibited a
fluorescence emission maximum of 350 nm. This is similar to data previously reported
for the non-His-tagged construct (Kosinski-Collins and King 2003) (Figure 3-4A).
Similarly, all of the triple mutant tryptophan constructs had denatured fluorescence
emission maxima of 350 nm. The native fluorescence emission maxima were 327 nm for
W42-only, 329 nm for W68-only, 318 nm for W130-only, and 327 nm for W156-only
(Table 3-1). W68-only and W156-only retained the native state quenching observed in
wild type (Figure 3-4C and 3-4E), while W42-only and W130-only were quenched in the
denatured state (Figure 3-4B and 3-4D). W130-only is significantly more fluorescent in
its native state than any of the other triple mutant constructs.
Table 3-1
Fluorescence Spectra constants for triple tryptophan mutants of HyD-Crys
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Wild type W42-only W68-only W130-only W156-only
Native 326 nm 327 nm 329 nm 318 nm 327 nm
Fluorescence
Emission Max
Denatured 350 nm 350 nm 350 nm 350 nm 350 nm
Fluorescence
Emission Max
Exhibit Native Yes No Yes No Yes
State Quenching?
D. DISCUSSION
i. Expression and structure of crystallin proteins
HyD-Crys is a highly stable protein containing four tryptophans buried within two
highly hydrophobic protein cores. Four stable, triple mutants of His-tagged HyD-Crys
were produced each containing one native tryptophan and three tryptophan to
phenylalanine substitutions. All of the mutant proteins were expressed in E. coli in the
soluble fraction of the cell lysate. In addition, each had a primarily P-sheet character by
circular dichroism measurements and displayed bands of a similar mobility as wild type
on a native polyacrylamide gel.
The triple tryptophan mutants display no increased or decreased propensity for
aggregation over wild-type HyD-Crys during either refolding or long-term storage at 40C.
The overall solubility and native-like structure of HyD-Crys with phenylalanines
substituted for tryptophans suggests that the tryptophan residues are not critical for
stability at physiological temperature. Likewise, mutation of each tryptophan and
substitution with alanine report similar stability (Veronica Zepeda, Melissa Kosinski-
Collins, Shannon Flaugh, and Jonathan King, unpublished results). Given the location of
these substitutions in the hydrophobic core of HyD-Crys, the high solubilities and native-
like structures of all mutant tryptophan constructs are surprising.
All four tryptophans in HyD-Crys show high chemical conservation throughout
the known members of the y-crystallin family. Trp42 and Trp130 are 100% conserved
throughout the y-crystallin family as aromatic residues, while Trp68 and Trp156 are 80%
and 89% conserved in aromaticity, respectively. The deviations in aromatic composition
in Trp68 and Trp156 are found in primarily aquatic animals such as carp and catfish. It is
interesting to note that the eyes of these animals are shielded from direct light by their
underwater surroundings.
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ii. The quenching of tryptophan emission in the native state
Based on fluorescence spectra data collected from the triple mutant tryptophan
proteins, it appears that Trp68 and Trp156 are responsible for the native state quenching
phenomenon in HyD-Crys. Trp68 is in domain I and Trp 156 is in domain II.
Examination of the 3-dimensional structure of HyD-Crys revealed that both are located in
similar positions within the domains.
Because both Trp68 and Trp156 exhibit anomalous quenching, it seemed likely
that the residues responsible for this reaction would be similar in the two domains, given
the high sequence similarity between domain I and domain II of HyD-Crys. Inspection of
the residues within 8 A of Trp68 and Trp 156 showed that the only potential quenchers
that were constant between the two domains were two tyrosine residues and histidine.
Tyr55, Tyr62, and His65 make a "cage" around Trp68 (Figure 3-5A), while Tyrl43,
Tyrl50, and His122 surround Trpl56 (Figure 3-5B). Chen and Barkley have suggested
that tyrosine may quench tryptophan fluorescence via a proton-transfer mechanism while
histidine may quench via excited state electron transfer (1998). Both interactions have
geometry requirements for quenching. As histidine quenches primarily when protonated
and as these experiments were performed at pH 7.0, tyrosine is the likely side chain
participating in the quenching phenomenon.
Both Trp42 and Trp 130 are located within quenching distance of cysteine and
histidine side chains. In the original report of the crystal structure of bovine yB crystallin,
Wistow et al. suggested that these interactions may have been the source of the
anomalous quenching (1983). Though the results reported here make that mechanism
less likely, the cysteine and histidine residues surrounding Trp42 and Trp 130 may protect
these tryptophans from photo damage in vivo.
iii. Tryptophan quenching and protection from UV radiation
All lens proteins are subject to irradiation in the visible and ultraviolet light range
during the human lifetime. The cornea of the eye absorbs the majority of light at
wavelengths less than 295 nm, allowing ultraviolet light at wavelengths longer than 295
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nm to pass through to the lens and to the crystallin proteins (Sliney 2002). Although the
peak of tryptophan absorbance occurs at 278 nm, like most tryptophan containing
proteins, HyD-Crys shows an absorption tail that extends well beyond 300 nm (3-3A).
It is not obvious why the tryptophan residues are conserved in the y-crystallin
family, but these residues are responsible for the major observed ultraviolet light
absorption events of y-crystallins in vitro. The well-conserved tryptophans in the y-
crystallins may have been maintained during evolution as a part of the mechanism of
protecting the retina and other eye structures from UV-B damage. This, however, would
then render the y-crystallin proteins themselves sensitive to ultraviolet light damage. In
epidemiological studies, excess UV-B exposure has been shown to be directly correlated
with an increase in mature onset cataract in humans (Taylor et al. 1988; Sliney 2002).
More specifically, photo oxidation of tryptophan residues is known to be a precursor in
the formation of brunescent cataracts and is thought to occur as a result of prolonged
exposure to ultraviolet light (Pirie 1971; Kruzel et al. 1973; Zigman et al. 1973; Davies
and Truscott 2001; Soderberg et al. 2002). To avoid covalent modification associated
with extended exposure of tryptophan residues to ultraviolet light, the crystallins would
require a means to dissipate the absorbed excited state energy.
HyD-Crys was more fluorescent in its native state than in its denatured state
(Figure 3-4). Although not emphasized in the literature, yS and yB crystallins show this
anomalous quenching of their buried tryptophans as well (Rudolf et al. 1990; Wenk et al.
2000). The existence of native-state quenching of tryptophans in a protein exposed to
ultraviolet light, but selected for its stability and solubility, may reflect a role in
protecting it from the absorption events. Prolonged exposure to ultraviolet light or other
oxidative conditions populated in the lens over time by HyD-Crys may generate ring
opening and other covalent damage well characterized in other systems
(Balasubramanian et al. 1990; Prinsze et al. 1990; Conti et al. 1988). The generation of a
charged species within the buried core of the crystallins would be expected to destabilize
the protein and cause full or partial unfolding. These species would be candidates for
precursors to the aggregated state of the crystallins found in mature onset cataracts.
110
-
Figure 3-5
X-ray structure of Tyr-His-Tyr aromatic "cage" surrounding Trp68 (A) and Trp 156 (B).
Trp68 is enclosed by Tyr55, Tyr62, and His65, while Tyr143, Tyr150, and His122
surround Trp156 (Basak et al. 2003).
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CHAPTER IV: IDENTIFICATION OF AN INTERMEDIATE DURING
UNFOLDING AND REFOLDING OF HUMAN TD CRYSTALLIN USING
TRIPLE TRYPTOPHAN TO PHENYLALANINE MUTANT PROTEINS
A. INTRODUCTION
Human yD crystallin could be refolded to its native state at 37 °C after dilution
out of denaturant (Kosinski-Collins and King 2003). An in vitro aggregation pathway of
HyD-Crys that competed with productive refolding was identified and may be related to
the mechanism of its involvement in mature onset cataracts (Kosinski-Collins and King
2003). The structures of the intermediates in the aggregation pathway were studied
using atomic force microscopy and consisted of ordered, distinct intermediates. Using
fluorescence spectroscopy, a partially-folded hydrophobically collapsed intermediate was
also identified in the productive refolding pathway. Within the lens, partially unfolded
crystallin intermediates are likely to be recognized by the chaperone, a-crystallin (Fu and
Liang 2003; Cobb and Petrash 2002; Bron et al. 2000).
Given the two-domain structure of HyD-Crys, it seemed possible that the
intermediate identified in the aforementioned kinetic experiments had one intact domain
and one partially unfolded domain. Previous studies of a bovine homolog of HyD-Crys,
yB crystallin, showed that the protein could be denatured by urea at pH 2.0, but not at pH
7.0, and could be refolded over all reported concentrations of urea. The protein exhibited
a three-stage transition in these equilibrium studies, representing sequential denaturation
of the C-terminal and N-terminal domains at pH 2.0 (Rudolph et al. 1990; Mayr et al.
1997; Jaenicke 1999). Conversely, the closely homologous human yS crystallin, a
protein also containing two domains with four Greek keys, unfolded and refolded without
evidence of separate domain transitions (Wenk et al. 2000). HyD-Crys may possess
differential domain stability that was not detected in the apparent two-state unfolding
transition observed during equilibrium unfolding in GdnHCl. A partially-folded
intermediate with only one domain structured might be involved in the aggregation
pathway of HyD-Crys.
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We used triple mutant tryptophan constructs each containing only one of the four
native tryptophans of HyD-Crys to provide reporters of conformation for different regions
of the protein. This has made it possible to assess the thermodynamic stability and
kinetic properties of the two domains individually.
B. MATERIALS AND METHODS
i. Equilibrium refolding and unfolding
For the unfolding process, purified wild-type or mutant HyD-Crys was diluted to
10 tg/mL in increasing amounts of GdnHCl in S buffer from 0 to 5.5 M. The samples
were incubated at 37C until equilibrium was reached (about 6 hours). For the refolding
titration, 100 gg/ml protein was denatured in 5.5 M GdnHCl in S buffer at 370 C for five
hours. The protein was subsequently refolded by dilution to 10 ,gg/ml into decreasing
concentrations of GdnHCl from 5.5 to 0.55 M. The fluorescence spectra of the
equilibrated samples were determined using a Hitachi F-4500 fluorimeter equipped with
a continuous temperature control system with an excitation wavelength at 295 nm and
emission monitored from 310 to 420 nm. The excitation and emission slits were both set
to 10 nm. The ratios of emission intensities of 360 nm over 320 nm were used for data
analysis of wild type, W68-only, and W156-only, W42-only and W130-only. Fraction
unfolded values were calculated using the method of Pace et al. (1989) and denaturation
midpoints were calculated using the Kaliedagraph (Synergy Software) curve fitting
function.
ii. Unfolding fluorescence kinetics
Tryptophan environment changes with refolding were monitored using a Hitachi
4500 fluorimeter equipped with a continuous temperature control system. Native protein
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(100 ug/mL in S buffer at 370 C) was unfolded by dilution into S buffer to final
concentrations of 10 gg/ml HyD-Crys and 5.5 M GdnHCl using a syringe port injection
system exhibiting a dead-time of 1 second. Loss of global structure was monitored with
continuous excitation at 295 nm at 37C for 1 hour. Emission intensities during kinetic
unfolding were collected at 350 nm for wild type, W68-only, and W156-only while the
emission intensities were collected at 320 nm for W42-only and W130-only. The
fluorescence curves were fit to series of consecutive first-order exponentials using the
method described by Fersht (1999). The signals were all fit using the KaliedaGraph
(Synergy Software) curve fitting algorithm to mechanisms having one, two, and three
exponentials, and the best fit was selected by inspection. All proteins were unfolded in at
least two separate experiments to ensure the accuracy of the observed fluorescence and
curve fitting given the high levels of noise.
iii. Refolding fluorescence kinetics
Changes in tryptophan environment during refolding were monitored using a
Hitachi 4500 fluorimeter equipped with a continuous temperature control system. Native
protein was denatured at 100 gg/mL in 5.5 M GdnHCl in S buffer at 370 C for two hours.
The unfolded protein was refolded by dilution into S buffer to final concentrations of 10
jgg/ml HyD-Crys and 1.0 M GdnHCl using a syringe port injection system with a dead-
time of 1 second. Increase in global structure during refolding was monitored with
continuous excitation at 295 nm and emission at 350 nm for wild type, W68-only, and
W156-only and emission at 320nm for W42-only and W130-only. The fluorescence
curves were fit to series of consecutive first-order exponentials using the method
described by Fersht (1999). The signals were all fit using the KaliedaGraph (Synergy
Software) curve fitting algorithm to mechanisms having one, two, and three exponentials,
and the best fit was selected by inspection. These experiments were repeated for each
protein refolding to 1.0 M and 1.5 M GdnHC1.
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C. RESULTS
i. Equilibrium Refolding and Unfolding
Equilibrium unfolding and refolding experiments were performed on the triple
mutant tryptophan constructs of HyD-Crys to determine the stability of the individual
domains. Fluorescence spectra were collected as a function of GdnHCI concentration at
37°C as previously described (Kosinski-Collins and King 2003).
All four proteins showed a midpoint for denaturant-induced unfolding in the
range of 1-2 M GdnHCl. All four proteins also exhibited reversible refolding above 1.0
M GdnHCl. However, upon dilution to lower concentrations of denaturant, the proteins
exhibited a polymerization behavior similar to that described for wild-type HyD-Crys
(Kosinski-Collins and King 2003). Solution turbidity measurements of refolded samples
confirmed that the apparent increase in fraction unfolded values at low GdnHCl
concentrations was caused by signal obstruction due to aggregate formation (results not
shown). The equilibrium unfolding and refolding results are summarized in Table 4-1.
The equilibrium unfolding and refolding data were similar for mutant proteins
with tryptophans located in the same domain (Figure 4-1). The midpoint of the
denaturation transitions was 1.3 M for the two constructs that retain a native tryptophan
in domain I (W42-only and W68-only) and 2.0 M for those in domain II (W130-only and
W156-only). Only W156-only exhibited the slight hysteresis between unfolding and
refolding observed for wild type, having a midpoint of renaturation of 1.7 M. The
equilibrium unfolding and refolding transition of W42-only, W68-only, and W130-only
did not exhibit hysteresis. Further studies of residues in domain II near Trp156 may
elucidate the discrepancies in the unfolding and refolding pathway that are causing the
observed hysteresis.
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Figure 4-1
Equilibrium unfolding and refolding of His-tagged HyD-Crys in GdnHCl. Tryptophan
fluorescence was monitored during unfolding and refolding and all samples were
equilibrated in S buffer at a protein concentration of 10 ,gg/ml. A representative set of
fraction unfolded data is shown for wild-type (A), W42-only (B), W68-only (C), W130-
only (D), and W156-only (E). All protein data were analyzed using the ratio of
fluorescence emission intensities at 360 nm over 320 nm. Fraction unfolded values were
calculated from raw fluorescence intensity ratio measurements using the method
described by Pace et al. (1989). Unfolding (0) and refolding (0) transitions are presented
for each protein at 37°C.
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Based on the resistance of W42-only and W68-only to solvent denaturation,
domain I was less stable than domain II. Domain I exhibited an unfolding and refolding
transition midpoint at 1.3 M GdnHCl whereas domain II had a midpoint of 2.0 M
GdnHCl. This indicated that wild type equilibrium unfolding and refolding probably
contained a partially denatured intermediate not readily visible in the fluorescence spectra
of wild-type chains. However, it is important to note that if the tryptophan residues are
vital to stability of HyD-Crys, triple substitutions would likely affect the overall
thermodynamic parameters of the molecule. The altered transition midpoints of the
mutant proteins may simply reflect a global destabilization of the molecule due to these
changes.
Table 4-1
Equilibrium unfolding and refolding constants for the triple tryptophan mutant proteins of
HyD-Crys
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Wild type W42-only W68-only W130-only W156-only
Native 326 nm 327 nm 329 nm 318 nm 327 nm
Fluorescence
Emission Max
Denatured 350 nm 350 nm 350 nm 350 nm 350 nm
Fluorescence
Emission Max
Exhibit Yes No Yes No Yes
Native State
Quenching?
Exhibit Yes Yes Yes Yes Yes
Aggregation at
Low [GdnHCl]?
[GdnHC] at 1/2 2.8 M 1.3 M 1.3 M 2.0 M 2.0 M
Denaturation
[GdnHC] at 1/2 2.1 M 1.3 M 1.3 M 2.0 M 1.7 M
Renaturation
ii. Unfolding kinetics
The unfolding kinetics of HyD-Crys were studied by dilution of native protein
into 5.5 M GdnHCl and S buffer at 370C, pH 7.0 and monitoring the changes in the
fluorescence emission (Figure 4-2 and Table 4-2). A syringe injection port that exhibited
a dead-time of approximately 1 second was used as the mechanism of dilution. Figure 3-
6A shows the change in raw fluorescence signal for the four mutant proteins. Because
the quenching characteristics vary for each of the mutants, fluorescence emission of
W42-only and W130-only decreased upon denaturation whereas emission of W68-only
and W156-only increased upon unfolding. In figure 4-2B, the data have been normalized
between the native and denatured states for ease of visual comparison. As shown in
figure 4-2A, the major changes in fluorescence took place in the first thirty seconds of the
reaction. Millisecond time-scale intermediate(s) may have formed within the dead-time
of these experiments and are not directly addressed here.
The kinetic data suggest the presence of partially unfolded intermediates in the
transition between the native and unfolded states.
Wild-type His-tagged HyD-Crys was best fit with a four-state unfolding pathway
(Fersht 1999). The protein started as a native species and then formed two sequential
intermediates before becoming completely unfolded. In this model an early intermediate
(Iu1) was populated within a tl/2 of 1.0 s (Figure 4-2). A second partially unfolded
intermediate (Iu2) followed, forming with a tl/2 of 55 s. This intermediate was not as
quenched as native indicating the polar-tryptophan interaction had been disrupted. A
final unfolding transition (Iu2 -* denatured) occurred with a tl/ 2 of 120 s.
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Figure 4-2
Unfolding kinetics of His-tagged HyD-Crys monitoring intrinsic tryptophan fluorescence
with excitation at 295 nm. Emission was monitored at 350 nm for wild type, W68-only
and W156-only while emission at 320 nm was used for W42-only and W130-only.
HyD-Crys was denatured by rapid dilution into 5.5 M GdnHCl at 37°C in S buffer to a
final protein concentration of 10 gg/ml. A representative protein unfolding time course is
shown for wild-type His-tagged HyD-Crys (), W42-only (U), W68-only (l), W130-
only (), and W156-only (O). Data are shown over the first 150 seconds of unfolding,
although the data were collected over the entire unfolding process (- 1 hour). Raw
fluorescence emission values (A) and data normalized between native and denatured
emission intensities (B) are shown.
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The unfolding process for the domain I tryptophan constructs, W42-only and
W68-only, exhibited two transitions corresponding to the early unfolding steps of wild
type. These two protein exhibited changes in fluorescence signal that best fit to a three-
state unfolding model. Both proteins unfolded to the intermediate conformation with an
initial t1/2 of 1.4 s. W42-only had a subsequent transition from intermediate to denatured
with a t1/2 of 18 s and W68-only had a secondary tl/2 of 46 s. These values represent rate
constants that are similar to the k, and k2 rate constants observed in wild type (Table 4-2).
In comparison, the changes in the fluorescence signals upon unfolding for the
domain II tryptophan constructs, W130-only and W156-only, proceeded more slowly
than the changes in emission for domain I. The unfolding curves for tryptophans from
domain II were best fit to a three-state unfolding process involving a partially unfolded
intermediate. Neither mutant had a kl rate constant that was as large as that observed for
wild type. Instead, the domain II mutants showed an unfolding process with rate
constants that were similar to the k2 and k3 values of wild type. W130-only had t112
values of 12 s and 150 s for its two unfolding transitions, and W156-only had comparable
values of 15 s and 36 s.
When comparing the tryptophan residues in homologous positions in the two
domains, the unfolding curve trends were similar. The fluorescence signal observed for
Trp42 was similar to that of Trp 130 in that both had two unfolding transitions and
populated an partially unfolded intermediate. The overall trend of the unfolding curve
was similar for Trp68 and Trpl56 as well and both had a hyper-fluorescent folding
intermediate. This intermediate was likely a result of rapid relaxation of the tertiary
structure surrounding Trp68 and Trp156 resulting in a partial release of the tryptophan-
quencher interaction.
In addition, examination of tryptophans in homologous domain positions showed
that domain I unfolded before domain II. Trp42 had a more rapid change of global
environment than Trp 130 while the fluorescence emission of Trp68 increased its
fluorescent signal more rapidly than Trp 156. Wild type exhibited both of these
transitions and probably underwent sequential unfolding in which domain I unfolded
before domain II and an intermediate was populated with domain II folded but domain I
denatured.
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Table 4-2
Unfolding kinetic rate constants for the triple tryptophan mutants of HyD-Crys
kl t1/2 k2 t1/2 k3 T1/2
Wild type 0.2 3.5 s 0.038 18 s 0.0057 120 s
W42-only 0.1 7.9 s 0.039 18 s NA NA
W68-only 0.2 3.5 s 0.015 46 s NA NA
W130-only NA NA 0.060 12 s 0.0045 150 s
W156-only NA NA 0.046 15 s 0.019 36 s
iii. Refolding kinetics
In order to study the kinetic rates and intermediates formed during refolding of
HyD-Crys, fluorescence emission was monitored during refolding of denatured HyD-Crys
at 37C to a final denaturant concentration of 1.0 M GdnHCl in S buffer (Figure 4-3,
Table 4-3). Solution turbidity scans affirmed that no aggregate was formed under these
conditions for any of the proteins described.
Figure 4-3A shows the changes in the raw fluorescence signal during refolding for
the four triple tryptophan mutants. The major transitions occurred within the first 500
seconds of refolding. For ease of visual comparison, Figure 4-3B shows the refolding
fluorescence signals normalized between the denatured and native states. Intermediates
formed within the first second of refolding were not detected in these experiments.
Wild-type HyD-Crys was best fit to a three-state model suggesting the presence of
one partially folded intermediate along the productive refolding pathway (Fersht 1999).
The refolding reaction exhibited an early transition from denatured to a partially refolded
intermediate with a t1/2 of 15 s and a second transition of intermediate to native with a tl/2
of 190 s. The intermediate was more fluorescent than the denatured protein and the
native state was more fluorescent than the intermediate.
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Figure 4-3
Refolding kinetics of His-tagged HyD-Crys monitoring intrinsic tryptophan
fluorescence with excitation at 295 nm. Emissions were measured at 350 nm for wild
type, W68-only and W156-only while emission wavelengths of 320 nm were used for
W42-only and W130-only. HyD-Crys was denatured in 5.5 M GdnHCl at 37°C in S
buffer for 3 hours. HyD-Crys was refolded by rapid dilution with S buffer to a final
GdnHCl concentration of 1.0 M and a final protein concentration of 10 gg/ml for wild-
type His-tagged HyD-Crys (*), W42-only (U), W68-only (n), W130-only (0), and
W156-only (O). A representative scan of raw fluorescence signals (A) and signals
normalized between native and denatured fluorescence values (B) are shown. Data are
shown over the first 5000 seconds for raw fluorescence or 500 seconds for normalized
values for refolding, although the data was collected over 2 hours.
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Native (4.2)
The fluorescence signals of the domain I tryptophans reached a native-like state
more slowly than the signals from the domain II tryptophans. The fluorescence of
unfolding curves observed for W42-only and W68-only could be best fit to one
exponential suggesting a two-state refolding pathway. These chains refolded with t2
values of 190 s and 210 s respectively and neither populated an observable intermediate.
The refolding transitions of these domain I tryptophans correspond closely with the
second transition observed in wild type. The domain I constructs do not account for the
burst fluorescence kinetics observed in wild type.
The domain II tryptophan constructs, W130-only and W156-only underwent a
refolding process which was initially faster than domain I. These two proteins had
fluorescence refolding signals that were best fit to a three-state model suggesting the
existence of an intermediate. Both had initial tl/2 values that were similar to the
transitions observed for wild type. W130-only had an initial ti 2 of 27 s and a secondary
tl/2 of 300 s while the transitions of W156-only had values of 31 s and 150 s, respectively.
W130-only had a hyper-fluorescent intermediate and was the only construct
displaying a significant transformation within the dead-time of these experiments as
shown by a very high initial fluorescence signal upon the onset of refolding (Figure 4-
3A). It is possible that a millisecond refolding intermediate was populated by W130-only
that was not readily visible using the syringe injection port system. Further studies using
stopped-flow devices should be performed on this protein to assess the significance of
this putative early transformation in the refolding pathway.
From these data, it appeared that domain II refolded first and was then followed
by refolding of domain I (Figure 4-3B). A global hydrophobic collapse likely occurred in
domain II that was then slowly followed by tight packing of the domain II tryptophans
into their proper orientation. This resulted in the population of an intermediate with a
primarily intact domain II, but a denatured domain I. While Trp130 and Trp 156 were
being tightly packed, a nearly simultaneous hydrophobic collapse of domain I occurred as
evidenced by the change in fluorescence of Trp42 and Trp68. This two-step process
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resulted in the formation of a protein with native-like tertiary structure as seen by a
stabilization in tryptophan fluorescence emission.
Table 4-3
Refolding kinetic rate constants for the triple tryptophan mutants of HyD-Crys
kl t1/2 k2 tl/2
Wild type 0.047 15 s 0.0036 190 s
W42-only NA NA 0.0036 190 s
W68-only NA NA 0.0033 210 s
W130-only 0.022 30 s 0.0023 300 s
W156-only 0.022 30 s 0.0047 150 s
D. DISCUSSION
i. Stability of crystallin triple tryptophan mutants
Equilibrium unfolding and refolding experiments in GdnHCl demonstrated that
the triple mutant tryptophan constructs were destabilized compared to wild type (Figure
4-1). Native to denatured transition midpoints of 1.3 M GdnHCl were measured for
W42-only and W68-only and 2.0 M GdnHCl for W130-only and W156-only. Wild type
had an equilibrium unfolding midpoint of 2.8 M GdnHCl. The decreased transition
midpoints of the triple tryptophan mutants are likely due to destabilization of the
molecule cause by the triple mutations. Substitution of three tryptophans for
phenylalanines probably strains the hydrophobic cores of the molecules allowing
GdnHCl to enter and denature these areas of the protein at lower concentrations than wild
type. However, HyD-Crys with single tryptophans substituted by alanine folded into
native-like soluble monomers with stabilities equal to that of wild-type HyD-Crys
(Veronica Zepeda, Melissa Kosinski-Collins, Shannon Flaugh, and Jonathan King,
unpublished results).
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Figure 4-4
Model of HyD-Crys folding and aggregation. Upon rapid dilution into refolding buffer,
denatured HyD-Crys had a putative intermediate that had domain II folded and domain I
unfolded. During unfolding in GdnHCl, domain I unfolded earlier than domain II likely
populating a similar intermediate.
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ii. Unfolding and refolding intermediates
Kinetic analysis of HyD-Crys revealed that unfolding and productive refolding
involve a similar intermediate state in which tertiary structure is absent from domain I,
but present in domain II (Figure 4-4). The population of this single domain conformer
may represent an intermediate important in the in vitro aggregation pathway previously
described (Kosinski-Collins and King 2003). Structurally distinct folding intermediates
have been shown to be important in many aggregation pathways and disease systems
(Haase-Pettingell and King 1988; Wetzel 1994; Speed et al. 1995). The domain-
swapping model would provide a mechanism to explain polymerization of such partially-
folded two-domain species into an ordered fibrillar state (Rousseau et al. 2003; Liu and
Eisenberg 2002). Additionally, such partially folded species may be related to the
crystallin conformers recognized by ao-crystallin (Das et al. 1999; Cobb and Petrash
2002). Specifically, a-crystallin has been shown to bind and recognize molten globule,
partially folded states of the fry-crystallins as well as many other non-lens proteins such
as alkaline phosphatase, alpha-lactalbumin, and apolipoprotein C-II (Tanksale et al. 2002,
Bettelheim 2002, Hatters et al. 2001)
These data provide an explanation for tertiary structure of the domain cores.
However, we do not yet know what contributions interface formation makes in the
folding of HyD-Crys. Future studies will investigate the kinetic and thermodynamic
significance of domain interface residues in folding of the molecule.
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CHAPTER V: CHARACTERIZING THE UNFOLDING AND REFOLDING
PATHWAY OF HUMAN yS CRYSTALLIN AND N143D; A DEAMIDATED
MUTANT IDENTIFIED IN AGE-ONSET CATARACTS
A. INTRODUCTION
Human mature onset cataracts affect nearly 15% of the US population over 40
years of age and are the leading cause of blindness worldwide (NEI 2002). Pathological
studies of cataractous lenses have revealed that cataracts are composed of protein
aggregates that precipitate or polymerize in lens cells of the eye (Oyster 1999).
The proteins removed from cataractous human lenses are highly covalently
modified and often have cysteine or methionine oxidations, premature truncations, and
glutamine and asparagine deamidations, and/or tryptophan ring cleavages. It is still
unclear whether these modifications are the causative agents of the cataracts or occur
after the protein aggregates. It is possible, however, that changes such as these locally or
globally destabilize the native state making it more susceptible to aggregation.
Aggregation of a few protein molecules may seed the subsequent destabilization of other
polypeptides as seen with other protein folding disorders such as Alzheimer's disease
(AD), thus facilitating cataractogenesis.
The human ao-crystallins are thought to perform chaperone-like functions in the
lens, while the y-crystallins are primarily structural proteins. The f3-crystallins are
multimeric in solution while the y-crystallins are monomeric. Human yC, yD, and yS
crystallin are three y-crystallins that are appreciably expressed in the lens.
Human yS crystallin (HyS-Crys) is the major protein component of the adult
human lens and is primarily expressed in the lens fiber cells (Harding and Crabbe 1984).
Covalently modified HyS-Crys has been recovered in protein aggregates removed from
aged, cloudy lenses. The majority of high molecular weight HyS-Crys removed from
cataractous lenses is disulfide bonded (Lapko et al. 2002, Takemoto and Boyle 2000,
Takemoto 2001).
HyS-Crys has 178 amino acids and shows high sequence similarity to other y-
crystallins. The protein is presumed to be a two domain protein with both domains
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showing high levels of sequence conservation appearing to be the result of gene
duplication during evolution (Jaenicke 2000). Like most soluble y-crystallins, HyS-Crys
is monomeric in solution, but unlike other y-crystallins, the interdomain interactions are
weak (Wenk et al. 2000).
The C-terminal domain of HyS-Crys has been crystallized and shows high
structural similarity to other members of the crystallin family of proteins (Purkiss et al.
2002). Based on the crystal packing observed in x-ray diffraction of the C-terminal
domain, a probable model of HyS-Crys structure has been constructed using two
interacting C-termini to reflect the position and structure of entire molecule. In this
model, each domain of HyS-Crys is composed of anti-parallel n-sheets arranged in two
Greek-key motifs (Figure 5-1). There are four tryptophans in HyS-Crys (two in each
domain) that may be used to monitor fluorescence changes during unfolding and
refolding.
The stability and folding of intact HyS-Crys and its isolated N- and C-terminal
domains have been studied at pH 7.0 at 200 C by Wenk et al. (2000). Equilibrium
unfolding and refolding as a function of guanidine hydrochloride (GdnHCl) concentration
demonstrated that HyS-Crys displayed two-state reversible folding under these
conditions, although Chevron plot analysis suggested the presence of a kinetic
intermediate that was not directly identified. We have further investigated this
intermediate in fluorescence studies in an attempt to elucidate its involvement in
cataractogenesis in vivo.
Deamidated variants of HyS-Crys are present in many positions in cataractous
lenses including glutamine 92, glutamine 96, and asparagine 143 (Lapko et al. 2002;
Takemoto 2001; Hanson et al. 1998). A study of the high molecular weight fraction of
the insoluble portion of cataractous lenses revealed that, of these three positions,
asparagine 143 was the preferentially deamidated polar amino acid of HyS-Crys
(Takemoto 2001). No deamidation of this residue, however, was detected in the normal
lens (Takemoto and Boyle 2000). Harding and Crabbe have suggested that the
conversion of a neutral amino acid to a charged, unprotonated amino acid occurring
during deamidation may destabilize the protein perhaps favoring protein unfolding and
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aggregation (1984). Studies of PB 1-crystallins have shown that proteins deamidated in
the connecting peptide have altered domain association characteristics (Harms et al.). We
have investigated the in vitro unfolding, refolding, and aggregation pathways of N143D
HyS-Crys and compared these to wild type to determine if an alteration in folding makes
the mutant protein more susceptible to polymerization in the lens.
B. MATERIALS AND METHODS
i. Expression and purification
Wild-type and deamidated forms of HyS-Crys were expressed from a pQE
plasmid (Qiagen) in E.Coli M15 cells. Transformed cells were grown in 100 gg/mL
Ampicillin and 25 gg/mL Kanamycin at 37°C until log phase was reached. Protein
expression was induced with addition of 1.5 mM IPTG and grown for an additional four
to six hours. The cells were pelleted by centrifugation at 5,000xg for 10 minutes. The
cells were then lysed with 50 mM Tris, 1 mM EDTA, 300 mM NaC1, pH 8.0 and subject
to eight freeze-thaw cycles. The lysed pellets were dialyzed at 40 C three times against
0.1 M Na2SO4, 0.06 M NaH 2PO4, pH 7.0. The protein was resolved on a SW3000 gel
filtration column and the yS peak was dialyzed against distilled water with three changes
at 40 C. Protein concentration was determined using a Bradford assay and then the
samples were lyophilized (Bradford 1976). The protein samples were stored at -20°C
and were weighed and diluted directly into the buffers as needed for the described
experiments.
His-tagged HyD-Crys was purified as described from a pQE. 1 plasmid (Qiagen)
(Kosinski-Collins et al. 2003). The protein contained an N-terminal 6 histidine tag to
assist with purification.
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AFigure 5-1
Ribbon structure of the crystal packing of two C-termini of wild-type human yS crystallin
showing the location of residue 143 (Purkiss et al. 2002). Both the top view (A) and side
view (B) are shown.
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ii. Circular dichroism
CD spectra of wild-type and mutant HyS-Crys proteins were collected on an Aviv
Associates (Lakewood, NJ) model 202 circular dichroism spectrometer. All readings
were performed on 0.3 mg/mL HyD-Crys protein samples in 10 mM NaPO4, 5 mM DTT,
1 mM EDTA, pH 7.0. For wavelength spectra, CD was measured every 1 nm from 260
nm to 200 nm and averaged over 5 seconds. For thermal stability, CD was measured at
220 nm every 0.5°C between 20°C and 90°C nm. The protein was equilibrated at each
temperature for one minute and the signals were averaged over 5 seconds.
iii. Ultraviolet light absorbance
Ultraviolet light spectra of proteins were collected on a Varian Cary 50 Bio
ultraviolet light spectrometer. Concentration was calculated by measuring protein
absorbance at 280 nm and using an extinction coefficient of 41.04 mM-1 for both wild-
type and N143D HyS-Crys and 41.04 mM -1 for his-tagged HyD-Crys in 6.0 M GdnHCl.
Wild-type and N143D HyS-Crys had molecular weights of 21,006 Da. Mass
spectroscopy was performed on the purified protein to confirm that no DNA mutations
had been accumulated during the PCR plasmid preparation procedure. Isoelectric
focusing was used to confirm the presence of the deamidation mutation. His-tagged
HyD-Crys had a molecular weight of 21,844 Da.
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iv. Fluorescence emission spectra
Fluorescence emission spectra were read on a Hitachi F-4500 fluorimeter with a
continuous flow temperature control system. Proteins were diluted to a concentration of
200 mM ammonium acetate, pH 7.0 or 200 mM ammonium acetate containing 6 M
GdnHCl. Samples were excited at 295 nm and emission was measured from 310 nm to
420 nm. The excitation and emission slit widths were both set to 10 nm. The
background fluorescence of buffer or buffer and 6 M GdnHCl was subtracted out from
the sample reading. Fluorescence emission maxima were calculated by averaging signals
over every 5 nm and selecting the midpoint of the five signals that exhibited the highest
average.
v. Equilibrium refolding and unfolding
For the unfolding process, 100 gg/mL purified wild-type or N143D HyS-Crys was
diluted to 10 gg/mL in increasing amounts of GdnHCl in 10 mM NaPO4, 5 mM DTT, 1
mM EDTA, pH 7.0, from 0 to 5.5 M. The samples were incubated at 37°C until
equilibrium was reached (about 6 hours). For the refolding titration, 100 jgg/ml protein
was denatured in 5.5 M GdnHCl in at 37°C for five hours. The protein was subsequently
refolded by dilution to 10 gg/ml into decreasing concentrations of GdnHCl from 5.5 to
0.55 M. The fluorescence spectra of the equilibrated samples were determined using a
Hitachi 4500 fluorimeter equipped with a continuous temperature control system with an
excitation wavelength at 295 nm and emission monitored from 310 to 420 nm. The
excitation and emission slits were both set to 10 nm. The ratios of emission intensities of
360 nm over 320 nm were used for data analysis. Fraction unfolded values were
calculated using the method of Pace et al. (1989) and denaturation midpoints were
calculated using the Kaliedagraph (Synergy Software) curve fitting function.
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vi. Unfolding fluorescence kinetics
Tryptophan environment changes with refolding were monitored using a Hitachi
F-4500 fluorimeter equipped with a continuous temperature control system. Native
protein at 100 ug/mL in 10 mM NaPO4 5 mM DTT, 1 mM EDTA, pH 7.0 at 370C was
unfolded by dilution to final concentrations of 10 gg/ml HyD-Crys and 5.5 M GdnHCl
using a syringe port injection system exhibiting a dead-time of 1 second. Loss of global
structure was monitored with continuous excitation at 295 nm at 37C for 2 hours.
Emission intensities during kinetic unfolding were collected at 350 nm for wild-type and
N143D HyS-Crys. The fluorescence curves were fit to series of consecutive first-order
exponentials using the method described by Fersht (1999). The signals were all fit using
the Kaliedagraph (Synergy Software) curve fitting algorithm to mechanisms having one,
two, and three exponentials, and the best fit was selected by inspection. All proteins were
unfolded in at least two separate experiments to ensure the accuracy of the observed
fluorescence and curve fitting.
vii. Refolding fluorescence kinetics
Changes in tryptophan environment during refolding were monitored using a
Hitachi F-4500 fluorimeter equipped with a continuous temperature control system.
Native protein was denatured at 100 gg/mL in 5.5 M GdnHCl in 10 mM NaPO 4, 5 mM
DTT, 1 mM EDTA, pH 7.0 at 37°C for two hours. The unfolded protein was refolded by
dilution into 10 mM NaPO 4, 5 mM DTT, 1 mM EDTA, pH 7.0 to final concentrations of
10 gg/ml HyD-Crys and 0.55 M GdnHCl using a syringe port injection system with a
dead-time of 1 second. Increase in global structure during refolding was monitored with
continuous excitation at 295 nm and emission at 350 nm for both wild-type and N143D
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HyS-Crys. The fluorescence curves were fit to series of consecutive first-order
exponentials using the method described by Fersht (1999). The signals were all fit using
the Kaliedagraph (Synergy Software) curve fitting algorithm to mechanisms having one,
two, and three exponentials, and the best fit was selected by inspection. These
experiments were repeated for each protein.
viii. Refolding native gel electrophoresis
Wild-type and N143D HyS-Crys was unfolded in 10 mM NaPO4, 5 mM DTT, 1
mM EDTA, 5.5 M GdnHCl overnight at 37°C. The protein was then refolded by dilution
in 10 mM NaPO4, 5 mM DTT, 1 mM EDTA at 37°C to a final protein concentration of
10 gg/mL for various times. Native gel loading buffer containing DTT was added to
each sample and the protein was placed on ice. Samples were separated by
electrophoresis through a 9% polyacrylamide gel. The gel was run for three hours at 4°C.
Visualization was performed by silver staining as described (Rabilloud et al. 1988).
C. RESULTS
i. Purification and structure assignment of HS-Crys
Both wild-type and N143D HyS-Crys expressed in the soluble portion of the cell
lysate and folded into a native-like conformations.
Far-UV CD of the native proteins showed a primarily 5-sheet structure for wild-
type HyS-Crys and the N143D mutant protein 37C, pH 7.0 (data not shown). Both
proteins had a characteristic 5-sheet minimum at 218 nm indicating that the native states
were similar for both proteins.
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Figure 5-2
Fluorescence emission of native (·) and denatured (0) HyS-Crys. Protein was excited at
295 nm and emission spectra were collected from samples of 10 gg/mL protein in 200
mM ammonium acetate, pH 7.0 or buffer and 6 M GdnHCl at 37°C. Fluorescence
spectra of wild-type (A) and N143D (B) Hys-Crys are shown.
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The overall character of the fluorescence emission spectra of wild-type and the
N143D mutant of HyS-Crys were assessed by exciting the protein at 295 nm and
observing fluorescence emission intensities from 310 to 420 nm in either 200 mM
ammonium acetate, pH 7.0 buffer or buffer and made up to 6.0 M GdnHCl (Figure 5-2
and Table 5-1). Wild-type HyS-Crys had a native fluorescence emission maximum of
329 nm, and was quenched in the native state.
The denatured protein exhibited a fluorescence emission maximum of 350 nm.
This is similar to data previously reported (Wenk et. al. 2000). N143D displayed a
fluorescence emission maximum of 330 nm in the native state and 350 nm in the
denatured state. The N143D mutant displayed similar fluorescence and quenching
characteristics as wild-type although the overall fluorescence of the native state appeared
to be slightly higher.
ii. Stability of human yS crystallin
To assess the stability of the proteins, equilibrium unfolding and refolding
experiments were performed on both mutant and wild-type HyS-Crys as a function of
GdnHCl concentration (Figure 5-3). Fluorescence spectra were collected at 37C, pH 7.0
as previously described (Kosinski-Collins and King 2003).
Briefly, for unfolding, protein was added to increasing concentrations of GdnHCl
and allowed to incubate until equilibrium was reached. For refolding, the protein was
denatured for 5 hours and then refolded by addition to samples of decreasing GdnHCl
concentration and incubated until equilibrium was reached.
Both proteins exhibited a single, smooth transition between native and denatured
with no evidence of any stabilized intermediates. The refolding and unfolding
equilibrium curves were indistinguishable between the two proteins each having the same
transition midpoints at 37C.
These reversible, two-state protein unfolding/refolding transitions were analyzed
using the method described by Pace et al. (1997). Both proteins showed a midpoint for
denaturant-induced unfolding and refolding at 2.3 M GdnHCl with m-values of 5.5. Wild
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type had a AGH2 0 of 13 kcal/mol while N143D exhibited a AGH 20 of 12 kcal/mol. The
equilibrium unfolding and refolding results are summarized in Table 5-1.
Table 5-1
Equilibrium unfolding and refolding constants of HyS-Crys
Native Denatured AGH20 m- Concentration of Melting
Fluorescence Fluorescence value GdnHCl at /2 Temp
Emission Max Emission Max denatured
Wild type 329 nm 350 nm 13 kcal/mol 5.5 2.3 M 76°C
N143D 330 nm 350 nm 12 kcal/mol 5.5 2.3 M 76°C
Wild-type HyS-Crys showed the same characteristics at 25C as at 37°C. There
was no evidence of hysteresis in that the equilibrium unfolding and refolding equilibrium
transitions were the same (Figure 5-3C).
To further assess the stability of the proteins, CD temperature melts were
performed on wild-type and N143D HyD-Crys (Figure 5-4). CD measured at 220 nm in
10 mM NaPO4, 5 mM DTT, and 1 mM EDTA, pH 7.0 as a function of temperature.
Both proteins displayed a single unfolding transition with a midpoint 76°C. Solution
turbidity measurements indicated that both proteins aggregated at this temperature and
neither could be refolded by decreasing the temperature of the solution.
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Figure 5-3
Equilibrium unfolding and refolding of HyS-Crys in GdnHCl. Tryptophan fluorescence
was monitored during unfolding and refolding and all samples were equilibrated in 10
mM NaPO4, 5 mM DTT, 1 mM EDTA, pH 7.0 at a protein concentration of 10 ,gg/ml. A
representative set of fluorescence data is shown for wild-type HyS-Crys at 37C (A),
N143D 37°C (B), and wild-type at 250 C (C). All protein data was analyzed using the
ratio of fluorescence emission intensities at 360 nm over 320 nm. Unfolding (0) and
refolding () transitions are presented for each protein.
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Figure 5-4
Temperature denaturation of HyS-Crys monitored with circular dichroism. Protein was
prepared at 300 pg/mL in 10 mM NaPO 4, 5 mM DTT, 1 mM EDTA, pH 7.0. The far-
UV CD was monitored at 220 nm as the temperature was increased in the cuvette by
0.5°C for both wild-type HyS-Crys (A) and N143D (B).
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iii. Unfolding kinetics
The unfolding kinetics of HyS-Crys was studied by dilution of native protein into
5.5 M GdnHCl at 37°C and monitoring the changes in the fluorescence emission (Figure
5-5, Table 5-2). A syringe injection port that exhibited a dead-time of approximately 1
second was used as the mechanism of dilution. Because of the quenching characteristics
of HyS-Crys, fluorescence emission intensity increased upon unfolding for the proteins.
Millisecond time-scale intermediate(s) may have formed within the dead-time of these
experiments and are not directly addressed here.
Table 5-2
Unfolding kinetic rate constants of HyS-Crys
kl t1/2 k 2 tl1 /2
Wild type 0.13 5.3 s 0.0037 190 s
N143D 0.16 4.3 s 0.0077 90 s
The kinetic data suggest the presence of partially unfolded intermediates in the
transition between the native and unfolded states for both wild type and N143D. The
intermediates appear to be hyper-fluorescent in both species.
The wild type unfolding signals were best fit with a three-state unfolding pathway
(Fersht 1999). The protein started as a native species and then formed an intermediate
before becoming completely unfolded. In this model, an early intermediate (Iu) was
populated within a tl/2 of 5.3 s. A final unfolding transition (Iu - denatured) occurred
with a t1/2 of 190 s.
kN k2
Native > Iul - > Denatured (1)
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The N143D mutant displayed an unfolding fluorescence signal that fit with similar
unfolding kinetic rates as wild-type. The unfolding intermediate formed with a t2 of 4.3
s and the intermediate unfolded with a t/ 2 of 90 s.
These experiments were repeated in the absence of DTT and similar results were
obtained for both the wild-type and mutant HyS-Crys.
iv. Refolding kinetics
In order to study the kinetic rates and intermediates formed during refolding of
HyS-Crys, fluorescence emission was monitored during refolding of denatured HyS-Crys
at 37C to a final denaturant concentration of 0.5 M GdnHCl in 10 mM NaPO4, 5 mM
DTT, 1 mM EDTA, pH 7.0 (Figure 5-6, Table 5-3). Solution turbidity scans affirmed
that no aggregate was formed under these conditions for either wild-type or mutant HyS-
Crys.
Table 5-3
Refolding kinetic rate constants of HyS-Crys
kl tl/2 k2 t1/2
Wild type 0.084 8.3 s 0.0034 200 s
N143D 0.12 5.8 s 0.0014 490 s
Figure 6 shows the changes in the raw fluorescence signal during refolding for
both wild-type and N143D HyS-Crys. The major transitions occurred within the first 20
minutes of refolding. Intermediates formed within the first second of refolding were not
detected in these experiments.
Wild-type HyS-Crys was best fit to a three-state model suggesting the presence of
one partially folded intermediate along the productive refolding pathway (Fersht 1999).
The refolding reaction exhibited an early transition from denatured to a partially refolded
intermediate with a t1/2 of 8.3 s and a second transition of intermediate to native with a tl/2
of 200 s.
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Figure 5-5
Unfolding kinetics of HyS-Crys monitoring intrinsic tryptophan fluorescence with
excitation at 295 nm. Emissions were monitored at 350 nm for wild type and N143D.
HyS-Crys was denatured by rapid dilution into 5.5 M GdnHCl at 370 C in 10 mM NaPO 4,
5 mM DTT, 1 mM EDTA, pH 7.0 to a final protein concentration of 10 jig/ml. Raw
fluorescence signal from a representative protein unfolding time course is shown for
wild-type (A) and N143D (B). Data are shown over the first 600 seconds of unfolding,
although the data were collected over the entire unfolding process (- 1 hour).
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Figure 5-6
Refolding kinetics of HyS-Crys monitoring intrinsic tryptophan fluorescence with
excitation at 295 nm and emission at 350 nm. HyD-Crys was denatured in 5.5 M
GdnHCl at 37°C in 10 mM NaPO4, 5 mM DTT, 1 mM EDTA, pH 7.0 for 3 hours. HyS-
Crys was refolded by rapid dilution with S buffer to a final GdnHCl concentration of 0.55
M and a final protein concentration of 10 gg/ml for wild-type (A) and N143D (B) HyS-
Crys. A representative scan of raw fluorescence signals are shown over the first 600
seconds of refolding, although the data were collected over 2 hours.
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The fluorescence signal observed during the refolding of N143D could be fit to a similar
three state folding pathway as that observed for wild-type. The intermediate formed with
a t/ 2 of 5.8 s and then intermediate to native transition occurred with a tl/ 2 of 490 s.
We repeated these refolding fluorescence experiments in the absence of DTT and
obtained similar results for both proteins with no evidence of aggregation.
Wild-type and N143D HyS-Crys was refolded for various times and the resulting
species were resolved on a 9% native polyacrylamide gel.
For wild-type HyS-Crys, after five minutes of refolding one band was visible in
the lanes that corresponded to productively refolded native protein (Figure 5-7). An
intermediate formed in during the first 4 minutes of refolding. The intermediate did not
resolve into a discreet band, but was visualized as a wide, smeared mass of protein that
migrated significantly farther than the native protein. The native gel observation of the
formation of an intermediate within the first few seconds of refolding that disappears
within 4 minutes is consistent within the intermediate predicted in fluorescence
experiments.
For N143D HyS-Crys, a band corresponding to the migration distance of native
N143D was observed after 4 minutes of refolding (Figure 5-8). An intermediate that
migrated a farther distance than native formed within the first few seconds of refolding
similar to wild type. Traces of this intermediate, however, were visible in lanes
corresponding to up to 15 minutes of refolding. How and why this intermediate is
stabilized in N143D may provide insight into the process and effect of deamidation in the
lens.
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IV. DISCUSSION
i. Aggregation and refolding in human yS crystallin
HyS-Crys and HyD-Crys are found in the aggregates extracted from old
cataractous lenses (Lapko et al. 2002, Takemoto and Boyle 2000, Takemoto 2001,
Hanson et al. 2000). It is not known whether these proteins are co-aggregates or whether
their aggregation pathways are independent. An in vitro aggregation pathway was
identified for HyD-Crys when the protein was unfolded in GdnHCl and then refolded by
dilution to concentrations of GdnHCl lower than 1.0 M (Kosinski-Collins and King
2003). When wild-type and N143D HyS-Crys were refolded under the same conditions,
there was no evidence of aggregation in light scattering or solution turbidity
measurements (Figure 5-2).
ii. Deamidation at position 143 in human yS crystallin
Many posttranslationally modified proteins have been identified from cataractous
lenses. Studies have revealed that deamidation at asparagine 143 in HyS-Crys is a
primary covalent modification observed in the insoluble portion of cataractous human
lenses (Takemoto 2001). It is thought that deamidation may destabilize the native state
of HyS-Crys by charge addition, or alternately, the oxidative damage may follow initial
unfolding or aggregation.
The stability of wild-type and N143D HyD-Crys were assessed through
equilibrium unfolding and refolding experiments. The AGH2O of wild type was 13
kcal/mol and was 12 kcal/mol for N143D. Both proteins exhibited a two-state
denaturation transition at 2.3 M GdnHCl and neither protein exhibited any evidence of
hysteresis as observed with HyD-Crys (Kosinski-Collins and King 2003). In addition,
temperature melt analysis in the absence of GdnHCl revealed that both proteins had the
same denaturation temperature of 76°C. Together, this data demonstrates that N143D
was not significantly destabilized as compared to wild-type HyS-Crys.
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Figure 5-7
Wild-type HyS-Crys was unfolded in 5.5 M GdnHCI overnight and then refolded by
dilution into 10mM NaP04, 5mM DTT, 1mM EDTA, pH 7.0. From right to left, the
gel shows folded wild-type HyS-Crys and samples of 30 min., 25 min., 20 min., 15 min.,
10 min., 9 min., 8 min., 7 min., 6 min., 5 min., 4 min., 3 min., 2 min., 1.5 min., 1 min.,
0.5 min., and 0 min. of refolding. The location of the native protein and intermediate
bands are designated. The gel was run for three hours at 4°C.
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Figure 5-8
N143D HyS-Crys was unfolded in 5.5 M GdnHCI overnight and then refolded by dilution
into 10 mM NaP04, 5 mM DTT, 1 mM EDTA, pH 7.0. From right to left, the gel shows
folded N143D HyS-Crys and samples of30 min., 25 min., 20 min., 15 min., 10 min., 9
min., 8 min., 7 min., 6 min., 5 min., 4 min., 3 min., 2 min., 1.5 min., 1 min., 0.5 min., and
o min. of refolding. The location of the native protein and intermediate bands are
designated. The gel was run for three hours at 4°C.
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We further studied the in vitro unfolding and refolding pathway of wild-type and
N143D HyD-Crys. During unfolding, fluorescence changes revealed that both proteins
went through a partially denatured, hyper-fluorescent intermediate (Table 5-2). Based on
the time of formation of the intermediate for wild-type and N143D HyS-Crys, the
partially unfolded species more than likely had the same overall structure for both
proteins. The fluorescence signals observed during the refolding of wild-type and
N143D HyD-Crys are similar as well. Both proteins refolded through a partially
unfolded conformation and had similar kinetic rate constants (Table 5-3). This is more
than likely the intermediate proposed to exist in wild type during isolated domain studies
performed by Wenk et al. (2000). It appeared as though this intermediate was longer
lived in N143D than in wild-type HyS-Crys in native gels, although this may simply be
an artifact of the ice incubation of the protein before resolution on the gel. We cannot
precisely determine whether or not the unfolding and refolding intermediates were the
same for either protein. Overall, these data suggest that an aspartic acid at position 143
did not affect the overall characteristics of protein folding in vitro.
Our results reveal that the unfolding and refolding pathways of wild-type and
N143D HyS-Crys were very similar and N143D was not destabilized as compared to wild
type. This indicated that the final deamidated form of aspartic acid at position 143 was
not important for HyS-Crys folding and stability. This, however, does not reveal the role
of deamidation to HyS-Crys destabilization and unfolding in general. Previous studies
have suggested that deamidation in proteins may occur via a succinimide intermediate
(Fujii et al. 1999; Aswad et al. 2000). Specifically, studies by Takemoto et al. have
shown that this is likely in the N143D mutation of HyS-Crys (2001). Insoluble HyS-Crys
removed from cataractous lenses contained both L-beta-aspartate and L-alpha-aspartate
indicating that it formed through an L-Succinimidyl intermediate. It is possible that it is
the succinimidyl intermediate of N143D that alters HyS-Crys folding and stability in vivo
and future studies should examine the affect of the cyclic intermediate on the protein.
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iii. Role of chaperonin recognition
The discussion above assumes that the impact of deamidation is to perturb the
initial conformation of HyS-Crys creating a disrupted structure that is more prone to
proceed down an aggregation pathway. As noted earlier, the recovery of deamidated
proteins from the cataract leaves open the question of whether the events are primary or
secondary.
An alternate possibility is that deamidation may interfere with recognition of
HyS-Crys by the a-crystallins or a deamidated residue in HyS-Crys may serve as the a-
crystallin recognition site directly. In fact, deamidated amino acids may be among the
signals that a-crystallin uses to recognize non-native crystallin species. In such models
some initial stress would result in partial unfolding, sensitizing the protein to oxidative
damage.
Unfortunately it is not known whether the oxidized Py-crystallins found in
cataracts are complexes with a-crystallin or with each other. Inclusion in the cataract
could reflect either efficient recognition, or failure of recognition of a-crystallin. To sort
this out, we should determine the partners of oxidized crystallins within the cataract, and
study the interaction of HyS-Crys and a-crystallin in vitro.
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CHAPTER VI: RECRUITMENT OF HUMAN yS CRYSTALLIN TO THE
HUMAN yD CRYSTALLIN AGGREGATION PATHWAY
A. INTRODUCTION
HyS-Crys has 69% sequence similarity and 50% sequence identity with HyD-
Crys. HyS-Crys has a three amino acid N-terminal extension of Ser-Lys-Thr and a two
amino acid domain linker extension of His-Leu not present in HyD-Crys. HyS-Crys was
historically thought to be present only in the lens fiber cells; however, recent evidence
from Beebe and colleagues suggests that it may be in the lens epithelium as well.
HyD-Crys is expressed primarily early in life and predominately in the lens
nucleus. HyD-Crys could be refolded to its native state at 37C after dilution out of
denaturant (Kosinski-Collins and King 2003). An in vitro aggregation pathway of HyD-
Crys that competed with productive refolding was identified and may be related to the
mechanism of its involvement in mature onset cataracts (Kosinski-Collins and King
2003). It is important to note, however, that native, soluble, HyD-Crys is thought to be
more nuclear in the lens and HyS-Crys is thought to be more cortical. It is unlikely,
therefore, that disrupted HyD-Crys localized to the lens nucleus would be able to recruit
native, unsecreted HyS-Crys. But, because both HyD-Crys and HyS-Crys are found in
cataract, we have investigated whether or not aggregation of HyD-Crys can recruit or
seed HyS-Crys aggregation in vitro.
B. MATERIALS AND METHODS
HyD-Crys and HyS-Crys were unfolded in 5.5 M GdnHC1 at 100 ug/mL overnight
at 37°C. Equal amount of denatured or native HyS-Crys and denatured HyD-Crys were
mixed and then refolded by a ten-fold dilution into 10 mM NaPO 4, 5 mM DTT, 1 mM
EDTA, pH 7.0 to a final denaturant concentration of 0.55 M. For the time-dependent
aggregation recruitment experiments, samples of denatured HyS-Crys were begun
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refolding and then equivalent amounts of denatured HyD-Crys were added to the samples
after 0 minutes, 2 minutes, 10 minutes, 30 minutes, 1 hour, and 2 hours of HyS-Crys
refolding. The protein samples were allowed to refold together at 37°C for 3 hours and
then the solutions were centrifuged at 40,000 RPM for 1 hour. The supernatant was
decanted and the pellet was resolubilized in sodium dodecyl sulfate (SDS) containing P-
mercaptoethanol. The SDS containing protein samples were then boiled at 95°C for 30
minutes and resolved on a 14% SDS polyacrylamide gel. The protein bands were then
visualized using silver nitrate staining as described (Rabilloud et al. 1988).
In the case of the time-dependent aggregation recruitment experiment, the overall
amount of protein found in each lane was quantitated by measuring the intensity of the
bands. The calculated values were then corrected for the background lane intensity and
then normalized to the most intense band which was the HyD-Crys band observed from
HyS-Crys and HyD-Crys mixing at 0 minutes for each separate experiment. Final values
were calculated by averaging data collected from two separate experiments.
C. RESULTS
Though HyS-Crys did not aggregate on its own under the aforementioned
refolding conditions, we were interested in its behavior in the presence of aggregating
HyD-Crys.
Wild-type His-tagged HyD-Crys was denatured in 5.5 M GdnHCl and then
refolded to 0.55 M GdnHCl. Previous studies have shown that HyD-Crys aggregates
under these conditions (Kosinski-Collins and King, 2003). The resulting solution was
centrifuged at high speed and the aggregate was resolubilized in SDS and boiled. Lane 2
of figure 6-1A and 6-1B show the resolution of this species on a polyacrylamide gel.
There was only one band in each of these lanes corresponding to approximately 20,000
Da. There was no evidence of any high molecular weight species that were resistant to
SDS denaturation.
Wild-type His-tagged HyD-Crys and wild-type HyS-Crys were denatured
separately in 5.5 M GdnHCl at 37°C. Equivalent amounts of both protein solutions were
added together and refolded by rapid dilution into phosphate buffer at pH 7.0. When the
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resulting aggregate was resolubilized in SDS and resolved on a 14% SDS polyacrylamide
gel, it contained two major bands that migrated to slightly different distances (Figure 6-
1A, Lane 1). These bands corresponded to the migration distance of HyS-Crys
monomers and HyD-Crys monomers of approximately 20,000 Da. SDS denatured His-
tagged HyD-Crys migrates further on a polyacrylamide gel than HyS-Crys despite having
a larger molecular weight. In mass spectroscopy analysis of His-tagged HyD-Crys, we
have found that the His-tag degrades. It is possible that during SDS boiling and
denaturation, the His-tag of HyD-Crys is more susceptible to degradation thus decreasing
the predicted molecular weight of the protein and altering the gel migration distance. In
addition to the two major crystallin monomer bands, there were a large number of higher
molecular weight species resistant to SDS denaturation. The most visible bands
corresponded to species of a molecular weight between approximately 40,000 Da and
45,000 Da. This more than likely represents dimer species of various combinations of
HyS-Crys and HyD-Crys. There were several bands of lower molecular weight than
20,000 Da that probably represent degradation products of HyS-Crys and HyD-Crys. The
N143D mutant of HyS-Crys co-aggregated with HyD-Crys to approximately the same
degree as wild-type HyS-Crys and showed similar high molecular weight species (data
not shown). This data seems to indicate that the dimer is more resistant to SDS
denaturation than the aggregate.
When native HyS-Crys was added to refolding HyD-Crys, however, only one
band was visible on the SDS polyacrylamide gel corresponding to the migration distance
of HyD-Crys (Figure 6-1B, Lane 1). This indicated that native HyS-Crys could not be
recruited to the HyD-Crys in vitro aggregate under these conditions.
The recruitment of wild-type and N143D HyS-Crys to the HyD-Crys aggregate
was further studied in a time dependent manner. Denatured samples of HyS-Crys were
begun refolding and an equivalent amount of denatured HyD-Crys was added after 0, 2,
10, 30, 60, and 120 minutes. The samples were allowed to completely refold together
overnight and were then centrifuged at high speed. The resulting pellet was resolubilized
in SDS, boiled, and separated on a 14% acrylamide gel (Figure 6-2).
Both HyS-Crys and HyD-Crys were observed in all pellets although the amount of
protein incorporated into the aggregate decreased as HyS-Crys was given additional time
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to refold. Even though the overall concentrations of HyD-Crys and HyS-Crys were the
same, the amount of HyD-Crys found in the pellet was always more than HyS-Crys. The
intensity of the wild-type HyS-Crys resuspended pellet band was approximately 40-70%
of that of HyD-Crys. The intensity of the N143D HyS-Crys band was about 20-45% of
the HyD-Crys band. This data suggests that wild-type HyS-Crys is more prone to be
recruited to the HyD-Crys aggregate than N143D.
The intensity of the bands of HyS-Crys and HyD-Crys were quantitated and the
amount of protein relative to that observed when HyS-Crys and HyD-Crys were refolded
together from 0 minutes was determined (Figure 6-3). The intensity of the monomer
bands observed for wild-type and N143D HyS-Crys aggregation with HyD-Crys
decreased proportionally as a function of time. In the case of both wild-type and N143D
HyS-Crys, at least some of the protein refolded for two hours could still be pulled into the
HyD-Crys aggregate as demonstrated by the presence of a HyS-Crys monomer band in
these lanes. This indicated that perhaps some non-native protein was present in these
samples and was susceptible to aggregation.
In all samples of the time-dependent aggregation experiment, SDS-resistant, high
molecular weight aggregate formed. Additionally, there was one aggregate species that
was found in wild-type HyS-Crys samples that was not present in N143D samples. This
band is indicated on Figure 6-2.
D. DISCUSSION
HyS-Crys did not aggregate on its own when refolded by dilution out of
denaturant in vitro. Solution turbidity measurements of refolded HyS-Crys in both
kinetic and equilibrium experiments showed no evidence of polymerized protein species.
Another member of the y-crystallin protein family, HyD-Crys, aggregates when refolded
under these conditions (Kosinski-Collins and King, 2003).
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Figure 6-1
1 2
Recruitment of HyS-Crys to the HyD-Crys aggregate. Denatured (A) or native (B) HyS-
Crys protein was added to aggregating HyD-Crys. The solution was allowed to refold for
5 hours and then the resulting aggregate was resolubilized by boiling in SDS. The
resolubilized pellet was resolved on a 14% polyacrylamide gel. Lane 1 is SDS denatured
HyD-Crys aggregate alone and lane 2 is HyD-Crys aggregating with HyS-Crys.
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Figure 6-2
Time dependent recruitment of wild-type and N143D HyS-Crys to the HyD-Crys
aggregate. Refolding of denatured HyS-Crys was initiated and an equal concentration of
denatured HyD-Crys was added after 0, 2, 10, 30, 60, or 120 minutes. The protein
samples were allowed to refold together overnight and then the solutions were
centrifuged at 40,000 RPM. The resolubilized pellet was resolved on a 14%
polyacrylamide gel. Lanes 1 through 6 show the time dependent refolding and
aggregation of wild-type HyS-Crys and HyD-Crys, while lanes 7 to 12 show N143D
HyS-Crys and HyD-Crys. The time of addition of denatured HyD-Crys after HyS-Crys
refolding was begun is indicated at the top of the lanes.
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Figure 6-3
Quantitation of loss of band intensities for time dependent recruitment of HyS-Crys to the
HyD-Crys aggregate. The overall intensity of the monomer bands of both HyD-Crys and
HyS-Crys were measured and averaged from two separate refolding/aggregation
experiments. The percentages of protein found in the bands were calculated relative to
the most intense band observed in the experiment which was always the HyD-Crys
monomer band visualized at 0 minutes. Results from wild-type (A) and N143D (B) HyS-
Crys aggregation recruitment are shown. The relative amounts of the HyS-Crys (,
dotted line) and HyD-Crys (, solid line) monomers are depicted.
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Although denatured HyS-Crys did not aggregate alone in vitro, it could be
recruited to aggregating HyD-Crys as shown by the double band present in SDS gel of
the solubilized pellet. Native HyS-Crys, however, could not be recruited to the HyD-Crys
aggregate. The coaggregation phenomenon may have implications for in vivo
polymerization and cataract formation.
At least some HyS-Crys could be recruited to the HyD-Crys aggregate after it had
been refolded for up to two hours (Figure 6-2). This indicated that at least some non-
native species was present in these samples. There may have been a minutely populated
slow folding species of HyS-Crys. Kinetic refolding experiments showed that all
tryptophans had reached a native-like environment by thirty minutes. This suggested that
the non-native species of HyS-Crys that could be recruited to the HyD-Crys aggregate at
two hours had proper hydrophobic core packing but had incorrect domain interaction or
f3-strand alignment.
When HyS-Crys and HyD-Crys were refolded together, high molecular weight
species of approximately 40,000 to 45,000 Da were formed that could not be denatured
with SDS. These species were most likely dimers of various combinations of HyS-Crys
and HyD-Crys, because refolding HyD-Crys did not form any SDS resistant multimers.
These dimers may represent a highly stable species capable of nucleating further
aggregation in vitro. Further studies should address the mechanism of coaggregation of
HyS-Crys and HyD-Crys and determine the overall composition of the polymerized state.
When aggregated proteins are removed from old, cataractous lenses, they contain
many different crystallin proteins including HyS-Crys and HyD-Crys. When HyD-Crys
becomes destabilized in the lens and begins to aggregate, perhaps other destabilized
proteins that cannot necessarily polymerize on their own such as HyS-Crys can be
recruited into the oligomerizing HyD-Crys species or vise versa. As the age of the
protein increases, this results in the accumulation of covalent modifications such as
deamidation and the formation of a succinimide intermediate of HyS-Crys. These
covalent changes may provide just enough tertiary structure destabilization of HyS-Crys
to allow it to be pulled into the HyD-Crys aggregate. High molecular weight species
removed from the lens should be studied to see if they can seed in vitro crystallin
aggregation.
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CHAPTER VII: CONCLUDING DISCUSSION
A. AROMATIC-AROMATIC RING INTERACTIONS IN HUMAN yD CRYSTALLIN
The nuclear crystallins present in the human eye lens are expressed early in life
and the proteins are present at up to 700 mg/mL. There is no protein turnover in mature
lens cells and, therefore, the crystallins are exposed to electromagnetic radiation and
other oxidizing stresses throughout the human lifetime. For all of these reasons, the
crystallin proteins must be extremely stable to stay in solution for proper function.
Below we consider the possibility of a network of aromatic interactions contributing to
crystallin stability.
Human yD crystallin (HyD-Crys) is a protein containing an extensive network of
aromatic ring interactions including four tryptophans, fourteen tyrosines and six
phenylalanines (Figure 7-1). Raman spectroscopy has revealed that the tyrosine residues
from all bovine y-crystallins are marginally hydrogen bonded (Pande et al. 1991). The
interactions between the aromatic residues of HyD-Crys may function as a stabilization
"network." Each individual ring-ring contact alone probably does not contribute very
much to the stability of the molecule given the tolerance of the molecule to tryptophan
substitution. However, the sum contribution of all of the aromatic stacks may be
important. This is different from the stabilization observed in coiled-coils where isolated
amino acid contacts contribute significantly to the stability of the complex (Lupas 1996).
Our studies have shown that the four tryptophans at the center of the hydrophobic
core of this protein are not vital for stability and can be triply substituted by
phenylalanine or singly replaced with alanine with no significant destabilization in terms
of protein solubility and/or Gibb's free energy; however, the quenching of Trp 68 and
Trp 156 implies particularly intimate noncovalent native-state interactions. Perhaps it is
not any individual residue that controls or dictates the stability of the molecule, but
perhaps it is the overall impact of the pi bond interactions caused by the entire aromatic-
aromatic ring stacking network that allow HyD-Crys to remain stable.
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Figure 7-1
Ribbon structure of human yD crystallin showing the location of aromatic network
(Basak et al. 2003). The structure is shown from the top (A) and the side (B).
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Many proteins are stabilized by aromatic-aromatic ring interactions including
small globular proteins like barnase and larger fibrous proteins such as collagen. One
example is the P22 tailspike protein which is a parallel P-helix protein. This protein has a
highly aromatic stack running up the center of the helix in which the rings sit one on top
of the other and the pi bond orbitals are aligned slightly divergent from parallel (Betts et
al. 2004).
In 1985, a study was published by Burley and Petsko that analyzed the frequency
and orientation of aromatic ring interactions in proteins. They found that aromatic rings
are most often found at an interaction distance of 4.5 to 7.0 A with 90° angles separating
the pi bond orbitals. Further analysis of paired aromatic residues argued that aromatic
rings preferred to align themselves in an "off-centered parallel" arrangement whereby the
ring of one residue is perfectly stacked flat upon the ring of the adjacent but not centered
completely (McGaughey et al. 1998). In addition, studies using double mutant cycle
analysis have shown that the contribution of an aromatic-aromatic pair to protein stability
is -0.6 to -1.3 kcal/mol (Serrano et al. 1991).
There is an extensive global aromatic network in HyD-Crys, and studies using
triple tryptophan mutants showed that the fluorescence quenching observed in the
molecule's native state is most likely due to two smaller local aromatic networks. One
network surrounds Trp68 and involves Tyr55, Tyr62, and His65, while the other
surrounds Trp 156 and involves Tyrl43, Tyrl50, and His122 (Basak et al. 2003). It
seems likely that HyD-Crys has multiple levels of aromatic ring stabilization involving
local and global protein sequence and structure. Although we have not determined the
structure of aggregated HyD-Crys yet, it is likely that there is a significant reorganization
of the aromatic network in the self-associated species. Raman spectroscopy of the
aggregated protein may provide insight into the orientation of the aromatic rings in this
species.
Inspection of HyD-Crys reveals that the majority of the aromatic residues are
located near the "top" of the molecule clustering around Trp68 and Trp156. With
exception of the tryptophans, many of the aromatic amino acids are found near the outer
edges of domain I and domain II and are at least partially solvent exposed.
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The tyrosine and phenylalanine residues of HyD-Crys seem to create a "ring"
around the outer edge of both domains. Because these residues are solvent exposed, it is
possible that the aromatic rings from one protein may interact with the tyrosine rings
from an adjacent protein. Particularly striking is the fact that the solvent exposed rings
tend to be found in pairs.
Close to the domain interface of the protein, Tyr45 interacts with Tyr5O at a 5.0 A
distance, and Tyr134 interacts with Tyr139 at a 4.9 A distance. Both of these pairs have
a side to face ring arrangement and may be important during interface formation or
domain reorganization in the folding pathway.
Of further interest in HyD-Crys are the interactions between Tyrl6 and Tyr28
located 4.5 A apart and Tyr93 and Tyr98 found 3.8 A apart. In both of these cases, the
two interacting tyrosine rings are virtually parallel to each other. The pairs are located at
opposite ends of the protein. Similarly, Tyr6 and Phel 1 interact at a distance of 4 A, and
Phel 16 and Phel 18 interact at a 3.5 A distance. These two pairs show a more typical
face to end ring configuration, but are also located at opposite ends of domain I and
domain II. Together, these four pairs create a symmetrical rectangle around the outside
edge of HyD-Crys and may provide an alignment platform for protein self association in
vivo. Aromatic ring interactions between multiple crystallin proteins may be important
for maintaining crystallin solubility and stability at the high protein concentrations found
in the eye lens.
Future studies should analyze that angle at which the rings interact in the x-ray
structure of HyD-Crys and assess the contribution of tyrosine and phenylalanine to
protein stability. It is possible that insight into ring stabilization and stacking in crystallin
may be applicable to other highly soluble proteins as well.
B. CRYSTALLIN FOLDING, AGGREGATION, AND HYSTERESIS
Cataract is caused by polymerization of the crystallin proteins. Given the high
concentration and stability of native crystallin in the lens, the aggregation-prone state of
the protein is most likely a partially unfolded or disrupted conformation. We have
investigated the thermodynamics and kinetics of HyD-Crys and human yS crystallin
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(HyS-Crys) unfolding, refolding, and aggregation in vitro to identify the partially folded
conformation and characterize the resulting aggregation process.
HyD-Crys exhibited an unfolding and refolding hysteresis at 37C that became
more pronounced at 25C (Figure 2-3) (Kosinski-Collins and King 2003). HyS-Crys did
not have an equilibrium unfolding and refolding hysteresis at 37C or 25°C (Figure 5-3).
Recent studies by Flaugh and King have shown that the unfolding and refolding
transitions of HyD-Crys overlay exactly after a 24 hour equilibration eliminating the
hysteresis (personal communication). In all of these studies, it was the position of the
unfolding transition that changed as a function of temperature and time. This indicated
that the unfolding pathway of HyD-Crys had a kinetically controlled barrier while the
unfolding pathway of human yS crystallin (HyS-Crys) did not. In addition, aggregation
of HyD-Crys was observed when the protein was denatured in GdnHCl and then refolded
into buffer, while HyS-Crys showed no aggregation propensity. It is possible that the
observed hysteresis and aggregation are related to direct differences in sequence between
HyD-Crys and HyS-Crys. Differences between the HyS-Crys and the HyD-Crys
primary sequences must control the in vitro aggregation process. HyS-Crys has 69%
sequence similarity and 50% sequence identity with HyD-Crys. HyS-Crys has a three
amino acid N-terminal extension of Ser-Lys-Thr and a two amino acid domain linker
extension of His-Leu not present in HyD-Crys.
Studies performed in our lab have shown that the interface residues of HyD-Crys
are important in unfolding and refolding of HyD-Crys (Flaugh et al. 2004, manuscript
submitted and S. L. Flaugh and J. A. King, manuscript in preparation). When the domain
interface residues of HyD-Crys were mutated, a partially unfolded folding intermediate
was stabilized. Jaenicke has suggested that the domain interactions are weaker in HyS-
Crys than in HyD-Crys, and it seems likely that the interface may be important in the
different aggregation character between the two proteins (1999).
The domain interface of HyD-Crys contains two interacting polar pairs of residues
around the two edges of the interface surrounding three pairs of hydrophobic interactions
near the center. The polar pairs of HyD-Crys are Glu54/Gln143 and Arg79/Met147 while
the hydrophobic pairs are Met43Vall1132, Phe56/Leu145, and Iso81/Vall1170. Based on
alignments of HyS-Crys with HyD-Crys, the hydrophilic pairs of HyS-Crys are
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Met57/Gln 148 and Arg82/Asp 152 while the hydrophobic pairs are Ala46/Iso 137,
Iso59/Leu 150, and Val84/Iso 175. The only notable differences between the two
interfaces are the loss of the aromatic (Phe56) in HyS-Crys and the placement of the salt
bridge at opposite sides of the domain interface. The changes in interface residues
between HyD-Crys and HyS-Cry appear minor and most likely do not account for the
differences in aggregation propensity or hysteresis formation observed in the two
molecules.
The unfolding and refolding equilibrium hysteresis may be a clue to the
mechanism of aggregation of HyD-Crys. Studies using triple tryptophan to phenylalanine
mutants of HyD-Crys showed that the origin of the hysteresis in HyD-Crys came from
residues surrounding Trp156 (Figure 4-1). The only triple tryptophan mutant displaying
an equilibrium unfolding and refolding hysteresis was Trp 156-only. Given that a kinetic
barrier exists to productive unfolding, there is probably a rigid region in this area of the
molecule that is resistant to denaturation (Figure 2-3). Perhaps this area of the molecule
forms a structured core from which the remainder of the molecule folds, and must remain
stable even in extreme conditions to retain the native structure of the overall protein.
Alternatively, perhaps as this region of the molecule unfolds, a non-native core of
interaction is stabilized that is not necessarily a productive on-pathway conformation. As
observed in interleukin- 1 , this region may represent an aggregation-prone "micro-
domain" that is resistant to unfolding and that forms rapidly when exposed to denaturant-
free buffer upon refolding. We cannot say decisively whether the "micro-domain" is
made up of native or non-native inter-residue contacts. Formation of isolated secondary
structural loops in this region may provide not only a nucleus for productive folding, but
may also be an area where potential non-native association may occur. It is of interest to
note that a truncation at Trp156 in HyD-Crys has been implicated in juvenile onset
cataract (Kmoch et al. 2000). Perhaps elimination of the "micro-domain" in this region
decreases stability of the molecule and opens a pocket for self-association. Clearly this
region must be important for maintaining global solubility of HyD-Crys.
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Figure 7-2
Ribbon structure of human yS crystallin showing the location of the conformationally
important prolines, Pro154 and Pro162 (Purkiss et al. 2002).
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We were interested in determining the residues responsible for the unfolding and
refolding hysteresis in this "micro-domain" so we examined all residues within 8 A of
Trp156 in the crystal structure of native HyD-Crys. We then aligned these residues
between HyS-Crys and HyD-Crys to identify any differences in the two sequences within
this region (Table 8-1).
Table 7-1
The residues within 8 A of Trp 156 in HyD-Crys that have amino acid
composition differences between HyS-Crys and HyD-Crys.
Residue in HyD-Crys Residue in HyS-Crys
Glutamic Acid 96 Glycine
Leucine 124 Cysteine
Asparagine 125 Lysine
Leucine 133 Phenylalanine
Tyrosine 154 Proline
Glutamine 155 Isoleucine
Threonine 160 Alanine
Alanine 162 Proline
Arginine 163 Alanine
In general, HyS-Crys seemed to have more hydrophobic residues surrounding
Trp156 than HyD-Crys. HyD-Crys had many acidic and basic residues in this region of
the molecule. It is possible that the presence of charges actually stabilizes the domain II
core to GdnHCl denaturation. It may require a higher concentration or a longer exposure
to GdnHCl for the denaturant to out-compete the existing polar interactions present in
this area in HyD-Crys. Hydrogen-deuterium exchange experiments coupled with NMR
will determine if residual structure is present in the core surrounding Trp156 in
denaturing conditions.
There were two specific differences that were particularly striking in the sequence
alignment between HyD-Crys and HyS-Crys. Position 154 is a tyrosine and position 162
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is an alanine in HyD-Crys and both align to two different prolines in HyS-Crys (Table 8-
1). These proline residues are located at the top of the molecule in a loop forming region
of HyS-Crys and are closely associated with the B-strand which forms the domain
interface of domain II (Figure 8-2).
Proline is the only amino acid that exhibits constrained movement around the a-
carbon bond in the peptide backbone. Perhaps by constraining the folding states that the
polypeptide backbone can sample in HyS-Crys, the prolines limit the number of folding
intermediates thus eliminating the kinetic barrier to productive unfolding or refolding
observed in HyD-Crys.
If formation or destruction of the "micro-domain" is an important step for the
productive unfolding of the molecule, it seems likely that any structural rigidity either
increasing the kinetic rate of "micro-domain" formation or limiting the number of
conformations sampled by the molecule would expedite HyS-Crys productive folding and
decrease or eliminate the aggregation pathway as well. Experiments performed by Clark
and colleagues at Notre Dame have shown that proline functions to prevent aggregation
of the P-helical pertactin protein of Bortella Pertussis (M. Junker, C. Schuster, K.
Whiteman, and P. L. Clark, personal communication). Alanine scanning of the "micro-
domain" residues of HyD-Crys may elucidate which if any of these residues are
responsible for the observed hysteresis and aggregation pathway.
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C. DOMAIN SWAPPING AS A MECHANISM FOR CRYSTALLIN AGGREGATION
Given the high structural similarity between the two domains of HyD-Crys (49%
similarity and 36% identity), domain swapping is a likely mechanism of aggregation for
this protein. In addition, studies utilizing triple tryptophan to phenylalanine mutant
proteins showed that a structure formed during unfolding and refolding that had domain I
denatured and domain II in a native-like conformation (Kosinski-Collins et al. 2004).
Disruption of interface contacts have further been shown to stabilize this intermediate
(Flaugh et al. 2004). If a partially unfolded conformation of HyD-Crys exists in solution,
it is likely that slow renaturation of the N-terminal domain may involve the formation of
both native intramolecular domain formation and non-native intermolecular domain
contacts resulting in domain swapping events.
Proline has been shown to be an important residue in domain swapping in
pl3sucl (Rousseau et al. 2001). In this protein, two prolines are located in the
conformational hinge region. One proline gives the protein the flexibility to rotate into a
domain swapped structure while the other proline provides a conformational constraint
that prevents high order oligomerization and aggregation (Silow et al. 1999). We have
hypothesized that the prolines in HyS-Crys are important to the stability and refolding of
HyS-Crys in the region of the "micro-domain". It is possible that the presence of the two
prolines in HyS-Crys function as "traffic guards" limiting the ability of the protein to
domain swap as well. HyD-Crys does not, however, have these two prolines in its
"micro-domain." Instead, HyD-Crys has an alanine and a tyrosine residue in place of the
prolines. These residues (alanine especially) do not force the conformational restrictions
on HyD-Crys inherhent to proline cis/trans isomerization. Perhaps structural flexibility
related to domain interface formation in HyD-Crys allows domain swapping and
aggregation to occur in this protein.
More exhaustive study of the aforementioned prolines may elucidate the
mechanism of hysteresis and aggregation in HyD-Crys.
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D. CONCLUDING REMARKS
Studies of HyD-Crys have identified an intermediate common to both the
unfolding and refolding pathway that retains native structure of the C-terminal domain,
but a disordered conformation in the N-terminal domain at pH 7.0, 37°C (Kosinski-
Collins et al. 2004). This refolding intermediate has recently been shown to be common
to the productive refolding and aggregation pathways (I. A. Mills, S. L. Flaugh, and J. A.
King, unpublished results). Studies by Rudolph et al. with bovine yB crystallin identified
a refolding intermediate that had a structure, N-terminal domain and an unfolded C-
terminal domain, when refolded in urea at pH 2.0 (1990). Folding studies in urea at 20°C
with rat PB2 crystallin, showed that an intermediate formed during unfolding that had an
intact C-terminal domain and a denatured N-terminal domain (Wieligmann et al. 1999).
A destabilized intermediate form of P3B2 has further been shown to be preferentially
bound by a-crystallin (Sathish et al. 2004). The presence of a partially unfolded
conformer of the py-crystallins may be important to the mechanism of aggregation and
cataract formation.
If one domain is unfolded and one domain of a y-crystallin is native-like, we can
imagine several possible scenarios for protein polymerization. The unfolded domain may
remain unfolded and simply aggregate as a disordered mat surrounded by the folded other
domain. It is possible that the unstructured domain may refold into a native-like
conformation, but use an adjacent molecule for formation of the domain interface
forming a domain-swapped structure. Alternatively, the unstructured domain may form
isolated n-strands that may insert into other productively refolded 3-sheets in a loop-sheet
insertion mechanism. Perhaps though, the unfolded domain refolds into a completely
different conformation like a parallel 1-helix that has exposed interaction surfaces simply
more prone to polymerization.
These possibilities merely assess the contribution of the py-crystallins, but we
know cataracts contain the a-crystallins as well. Assessing what type of disrupted
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conformations of the y-crystallins are present in the aged lens, and the propensity with
which these structures bind a-crystallin, may elucidate how and why protein
polymerization occurs in the lens.
The exact mechanism of cataract formation in the aged lens is unknown to date.
Numerous studies have been focused on identifying the causative agent of cataract, but
we have yet to identify a clear polymerization pathway for the crystallin proteins. It is
important to note that we rarely think of cataract as a specifically organized polymer
because of the amorphous nature of the high molecular weight species removed from old
lenses, but that does not mean that an organized core structure was never present. The
fibrous protein deposits identified in the brains of patients diagnosed with AD contain
many associated proteins in aggregated mats, even though the AO peptide forms amyloid
fibrils as the aggregation initiating species. In addition, studies of many different
aggregating proteins have demonstrated that a seed of polymerized protein may recruit
other protein species to the multimerizing chain. The organized nature of hereditary,
juvenile onset cataracts and the ability of the Py-crystallins to form in vitro amyloid fibers
suggests that mature onset cataracts may involve an ordered aggregate intermediate or
nucleus for formation.
We need to approach cataract as a possible ordered aggregation mechanism to
understand the underlying basis for the disease. We may have been misled by the
"unstructured" nature of the aggregated species removed from cataractous lenses and we
need to remember that organized aggregation is still a possibility for mature onset
cataract even though it is not immediately obvious from the lack of structure of material
removed. We need to also remember that there may be multiple paths that lead to
cyrstallin polymerization and aggregation and that no one mechanism may solely be
responsible for cataract. Ultimately, the process of cataractogenesis is extremely
complex and may require years of study and experiementation to understand.
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APPENDIX A: PROTEIN PARAMETERS
Protein parameters and constants calculated for human yD crystallin and human yS
crystallin (calculated using ProtParam tool from http://us.expasy.org/cgi-bin/protparam).
Protein Molecular E280 (1/nm) Theoretical pI
Weight (Da)
WT HyD-Crys 20,634 41.04 8.25
WT* HyD-Crys 21,844 41.04 8.53
W42-only WT* HyD-Crys 21,727 23.97 8.53
W68-only WT* HyD-Crys 21,727 23.97 8.53
W130-only WT* HyD-Crys 21,727 23.97 8.53
W156-only WT* HyD-Crys 21,727 23.97 8.53
W42A WT* HyD-Crys 21,702 35.35 8.53
W68A WT* HyD-Crys 21,702 35.35 8.53
W130A WT* HyD-Crys 21,702 35.35 8.53
W156A WT* HyD-Crys 21,702 35.35 8.53
WT HyS-Crys 21,007 41.04 6.44
N143D HyS-Crys 21,007 41.04 6.11
APPENDIX B: MUTAGENIC PRIMER TABLE
Mutagenic primers utilized in site directed mutagenesis of human yD crystallin to make
triple tryptophan to phenylalanine proteins.
Mutation Primers Tm
W42F coding 5'-gcg tgg aca gcg gct gct tta tgc tct atg agc agc-3' 87°C
W42F noncoding 5'-gct gct cat aga gca taa agc agc cgc tgt cca cgc-3' 87°C
W68F coding 5'-c gac cac cag ttt atg ggc ctc agc gac tcg-3' 87°C
W68F noncoding 5'-cga gtc gct gag gcc cat aaa ctg ctg gtg gtc g-3' 87°C
W130F coding 5'-gct gga ggg ctc ctt tgt cct cta cga gct gtc c-3' 87°C
W130F noncoding 5'-g gac agc tag agg aca aag gag ccc tcc agc-3' 87°C
W156F coding 5'-ggc gct acc act ttg ggg cca cga tg cc-3' 87°C
W156F noncoding 5'-ggc att cgt ggc ccc aaa gtc ctg gta gcg cc-3' 870C
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APPENDIX C: UNFOLDING AND REFOLDING EQUILIBRIUM DATA
ANALYSIS
I. Calculate the concentration of denaturant in each sample using the refractive index and
the following equations:
[Urea]A = 117.66- AN + 29.753. AN2 + 185.56 AN3
[GdmCl]A = 57.147 -AN + 38.68 AN2 - 91.60. AN3
II. Analyze samples using the 2-state folding curve analysis method described by Pace et
al. (1989). The fluorescence light intensity ot 350 nm or of 360 nm/320 nm was plotted
versus the denaturant concentration.
A. The native and denatured baselines were calculated.
B. The fraction of protein unfolded (fu) was calculated for each point in the
curve using the equation:
(YF Y)
(YF -Yu)
In this equation, YF was the value of y determined by the calculated fraction
folded baseline, y was the observed light intensity at any given point, and yu was
the value of y determined by the calculated fraction unfolded baseline.
III. The equilibrium constant (K) and the free energy change (AG) was then calculated
for each point in the curve using the following equations:
K- fu(l-f u)
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AG = -RT In K
In these equations, fu was the fraction of denatured protein present in any given
sample, R was the gas constant (1.987 calories/deg x mol) and T was the absolute
temperature.
IV. The resulting data were analyzed using the method described by Fersht (1999). The
light intensity of 360 nm/320 nm was plotted versus the concentration of denaturant and
then fit using the following equations:
A. To calculate the fraction unfolded curve fit:
(f fN) exp mD-N [rea]A AGH 2 })1RT
1+ exp {mDN [Urea]A - AGH20 }
RT
B. To analyze the raw data:
([Urea]A - [Urea], )
(aN + bN [Urea]A)+(a +bD [Urea]A) exp m-N RT
F= mD ([Urea]A -[Urea]) 2
1 + exp mD- N RT
In these equations, AG is the Gibb's free energy of the protein at 0 M denaturant, f was
the fraction unfolded baseline, fn was the native baseline, aN was the intercept of the
fraction folded baseline, bN was the slope of the fraction folded baseline, aD was the
intercept of the fraction unfolded baseline, bD was the slope of the fraction unfolded
baseline, [Urea]A was the actual urea concentration calculated by the refractive index in
any given sample, mD-N was the overall resistance of the protein to solvent denaturation
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(cal/mol x M), and [Urea]l/2 was the concentration of urea when half of the protein has
been denatured (M).
For Kaliedagraph curve fitting of fraction unfolded:
(l*(exp((ml *m0-m2)/0.8)))/(+(exp((ml*m0-m2)/0.8)))
mO = concentration of denaturant
ml = m-value
m2 = AGH20
For Kaliedagraph curve fitting of raw data:
((ml+m2*mO)+(m3+m4*mO)*exp(m5*((mO-m6)/0.8))))/( 1+
exp(m5 *((m0-m6)/0.8)))
mO = concentration of denaturant
ml = intercept of native baseline
m2 = slope of native baseline
m3 = intercept of native baseline
m4 = slope of native baseline
m5 = m-value
m6 = concentration of denaturant at transition midpoint
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APPENDIX D: UNFOLDING AND REFOLDING KINETIC CURVE FIT
CALCULATIONS
Data analysis of fluorescence changes during unfolding or refolding of human y-
crystallin proteins were calculated using the following parameters as described by Dr.
Stephen Raso.
I. For the reaction having no intermediate:
A B; with a rate constant k
[A] = Aoe -kt
[B] = Ao(l-e -k t)
Yobs = YA[A] + YB[B]
Yobs = YA(A0e -k t ) + YB(Ao(I-e-kt))
Because Ao and YA or YB are simply relative fluorescence differences, they may
be combined:
Yobs = YA'(e -k t) + YB'(1-e -k t)
Yobs = YA'(e -k t) + YB'-YB'(e-kt)
Yobs = (YA'-YB')(ekt) + YB'
For Kaliedagraph curve fitting:
(m2-m3)*(exp(-ml *mO))+m3
ml=kl
m2=YA (fluorescence of state A)
m3=YB (fluorescence of state B)
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II. For the reaction having one sequential intermediate:
A B C with rate constants kl and k2
For Kaliedagraph curve fitting:
m3*exp(-m1 *mO)+[(m4*(ml *exp(-ml *mO)-exp(-m2*mO)))/(m2-
ml)]+(m5)*(1+(m2*exp(-ml *mO)-ml *exp(-m2*mO))/(ml-m2))
ml=kl
m2=k 2
m3=YA (fluorescence of state A)
m4=YB (fluorescence of state B)
m5=Yc (fluorescence of state C)
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APPENDIX E: OLIGOMERIC RING STRUCTURES OF HUMAN yD
CRYSTALLIN
Figure 9-1
AFM height images of refolding HyD-Crys species absorbed to a mica surface. High
surfaces are denoted as white (5 nm) and low surfaces are shown in black (0 nm). HyD-
Crys was refolded for various times, extracted from solution, absorbed on mica, and
observed using tapping mode AFM. Fibers of wild-type HyD-Crys refolded for 40
minutes are shown in all panels. Panel A-C are 1 Jlm x 1 Jlm scanning areas while D is a
2 Jlm x 2 Jlm scanning area.
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Figure 9-2
AFM height images of refolding his-tagged HyD-Crys species absorbed to a mica
surface. High surfaces are denoted as white (5 nm) and low surfaces are shown in black
(0 nm). HyD-Crys was refolded for various times, extracted from solution, absorbed on
mica, and observed using tapping mode AFM. Fibers of wild-type HyD-Crys refolded
for 40 minutes are shown in all panels A and B while panel C shows images collected
after 30 minutes of refolding. Panel A shows protein in a 1 J.lmx 1 J.lmscanning area,
panel B shows protein in a 400 nm x 400 nm scanning area, and panel C is a 2.5 J.lmx 2.5
J.lmscannIng area.
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Wild-type or His-tagged HyD-Crys was unfolded in 5.5 M GdnHCl 37°C. The
protein was then refolded by dilution in 10 mM NaPO 4, 5 mM DTT, 1 mM EDTA, pH
7.0 at 37°C for various times. Ten AL of protein was spotted onto a cleaved mica
surface. Samples were dried for two hours by evaporation in a high vacuum desiccator.
Samples were then rinsed with 500 L of milli-Q H2 0 and dried for an additional two
hours by desiccation. The height and phase of the samples were analyzed by atomic
force microscopy using the tapping mode. Mica disks containing adhered protein were
stored under high vacuum at room temperature.
Long fibrous species of wild-type HyD-Crys were observed after 40 minutes of
refolding (Figure 9-1). The fiber length ranged from 300 to 700 nm. The fibers tended to
be localized in clusters where multiple thin filaments had associated and wound around
one another. In addition, the fibers had a central "core" from which the individual
filaments seemed to emerge. It is unclear as to whether the core was a thickly bundled
area of fibers or a nucleation center consisting of an alternate conformation of the
molecule.
His-tagged HyD-Crys was also observed after 20 to 40 minutes of refolding.
Instead of thin fibrils, however, circular oligomeric species were observed (Figure 9-2).
All of the rings observed had areas of low height at their center that were presumed to be
open cavities. The protein edge of all of the oligomers remained constant at
approximately 25 nm despite large differences in overall diameter.
The ring structures generally fell into one of four diameter size ranges. The
species were typically 60 nm, 80 nm, or 120 nm in diameter. A few oligomers, however,
were larger than 120 nm and we have categorized them as a class of their own due to
their size variability. The larger pores tended to create "puddles" absent of protein on the
mica within their central cavities. Of the over two hundred rings measured, most fell into
the 60 nm or 80 nm category. A more detailed analysis of the aggregates formed by
wild-type HyD-Crys lacking the His-tag confirmed that circular oligomers were present
amongst those aggregates as well.
"Did it ever get funny, because the part I saw was just weird."
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